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“If you want to find the secrets of the universe, 
think in terms of energy, frequency and 
vibration!” 
 
- Nikola Tesla 
ii 
 
Abstract 
Throughout this body of work low amplitude high frequency (500 Hz – 5000 Hz) mechanical 
stimulation and its effect to induce osteogenesis on bone marrow derived MSCs has been 
investigated. Due to the nanolevel amplitudes of these high frequency vertical vibrations the 
term nanokicking appeared to be appropriate and was subsequently used throughout this 
thesis to refer to these high frequency sinusoidal stimulations provided by the bioreactor. In 
the first instance this work was performed in 2D and biological analyses to determine 
osteogenesis were carried out at a transcript (mRNA), protein and mineralisation level. 
Affirmative results for osteogensis were observed from genes and proteins (RUNX2, 
osteocalin, osteopontin) related to the osteoblast phenotype by qRT-PCR, in cell western, and 
immunostaining. To determine the prescence of inorganic osseous minerals, more specific 
techniques such as Raman spectroscopy, micro-computed tomography and histological 
stainings (Von Kossa/Alizarin Red) were further employed. The results observed remained in 
line with previously published material (Gentleman et al., 2009) drawing the conclusion that 
calcium phosphate (Ca10(PO4)6, through nanokicking,was formed in vitro. 
The natural progession of this research meant that a novel vibrational bioreactor was 
conceived and designed, through the use of Lean and Six Sigma principles (Andrew Thomas, 
2004; Caldwell, 2006), in order to assess the potential of nanokicking in 3D. Here collagen 
was employed as a biomimetic scaffold and affirmative results for osteogenesis were 
observed.  
The bioreactor was unique in that long term (up to 46 days) sterile culture was achieved, it 
was easy to use and there was no requirement for osteogenic media, growth factors or 
complex chemistries (e.g. dexamethasone, rhBMP2)  in order to induce osteogenesis. The cost 
of use and maintence was relatively cheap compared to available commercial bioreactors 
(Rauh et al., 2011b). 
It is envisaged that this technology may one day have real world use for ossesous tissue 
regeneration and care in a GMP and clinical setting, or for the preparation of autologous 
tissue for medical testing in the burgeoning field of personalised medicine. 
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1.1   Introduction 
Throughout the 19th and 20th century we have seen various technological revolutions and 
advancements which have profoundly changed and improved (for the most part), the life of 
man. It can be argued that the first came in the field of chemistry in the Victorian Age at the 
turn of the 19th century and has continued up to this day. We are now able to manipulate 
reactions and processes to produce compounds and polymers like plastics and silicon (contact 
lenses, microprocessors) with unique properties and structures that can be used in everyday 
life. Towards the early to mid 20th century the next technological epoch came in physics 
where scientists, such as Boltzmann and Einstein proved that atoms truly existed and this 
knowledge could be used to calculate more efficient thermodynamics. This climaxed with the 
atomic age/fission and nuclear power whereby generating thousands of times more energy per 
mass compared to coal; the main energy source of the time. Presently, it could be said that we 
are on the threshold of another technological revolution that can profoundly improve the life 
of man. This time it is in the field of the biological sciences and regenerative medicine; 
whereby mastery of the stem cell and the human genome/proteome could help prolong not 
just life but also its quality. With this technology it could be said that western medicine would 
see a paradigm shift from, for the most part, not just alleviating the symptoms of chronic 
ailments to actually remedying debilitating conditions at their core. 
 
1.2  Tissue engineering and regenerative medicine 
 
Human beings are living longer than ever before and although positive, one of the downsides 
of this is the inevitable deterioration of a biological system, which is not intrinsically designed 
to last forever or moreover has limited regenerative capacity in main organs like the heart, 
brain/neural tissue and kidneys (Morishita, 2014). Dr. Micheal Lysaght was among the first to 
define this arena, its challenges and potential for downstream therapy for replacement of 
damaged tissue and organs (Lysaght, 1995; Lysaght and Hazlehurst, 2004; Lysaght and 
Reyes, 2001).  
Although it is becoming more difficult to unmarry the two it could be said that tissue 
engineering encompasses the use of auto / allografts and biomaterials while regenerative 
medicine can use biomimetic scaffolds and repairing modulating endogenous factors, with 
multi or pluripotent stem cells playing a crucial part, i.e. being able to differentiate into 
parenchymal or functional  cell types to replace that which has been damaged (Fisher and 
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Mauck, 2013). The idle goal of regeneration is the partial or complete restoration of damaged 
specialized tissues and/or organs returning full function and anatomical structure without the 
formation of fibrosis or scar tissue (Candiani et al., 2008; Lewis et al., 2009).  Surgery and the 
bodies innate healing abilities repairs but does not necessarily regenerate. As adults we have 
passed this physiological chronological development stage where we once had this full 
regenerative potential in the form of an embryo with toti and pluripotent cells (de Kretser, 
2007; Mintz, 1985; Morgani et al., 2013).  
 
A present rationale of note, in the use of grafts and tissue engineering which is making 
advancement is to devitalise an extra cellular matrix (ECM) and then revitalize this matrix 
with autologous cells. Several works have shown positive results; for example in 2009 a life 
was saved through the first transplantation of an engineered airway using a devitalised 
cadaveric implant in vivo (Macchiarini et al., 2008), and  in animal models this rationale has 
also been used with varying levels of success for the regeneration of the lungs (Ott et al., 
2010; Petersen et al., 2010), the liver  (Uygun et al., 2010), the perfusion of vascular allograft 
from cadaveric tissue (Wilshaw et al., 2012), and synthetic polymer scaffolds (Dahl et al., 
2011). Interestingly, there have also been publications on the re-enervation of 
musculo-skeletal tissue (Kang et al., 2012) and preparation of skeletal allografts to support 
mesenchymal stem cells vitalization for further mineralisation (Coquelin et al., 2012).   
 
Commercial regenerative research to address unmet medical needs (so called neo-organs and 
neo-tissues) in urologic, renal, gastrointestinal and vascular diseases has also gone on to form 
spin-out companies like Tengion Inc. with early phase I and II clinical trials for real world 
application of this technology (Basu et al., 2011; Basu et al., 2012; Kelley et al., 2010).  The 
burgeoning linkage between gene therapy and cell therapy/regenerative medicine has also 
seen the onset of research using induced pluripotent stem cells in UK companies like 
ReNeuron (Damasceno-Oliveira et al., 2007; Finger et al., 2007; Myers et al., 2007) and 
actual clinical  trials using adult neural stem cells in US companies like Neuralstem Inc. for 
treatment of conditions such as stroke, Alzheimer’s and Parkinson’s disease (Bautista et al., 
1994; Miyauchi et al., 1991). Also in the realms of Big Pharma the UK based company 
Glaxosmithklein has also invested in cell and gene therapy autologous hematopoietic stem 
cells with indications for ADA-SCID, WAS, MLD and Beta Thellassemia. 
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1.3   Bionanotechnology 
As mans engineering ability continues to improve and become more precise we are now 
realising benefits that have emerged in moving from the macro to the microscale, and now 
from the micro to the nanoscale for biological applications (Crowder et al., 2013). 
Bionanotechnology is the field of biology which uses devices or implementations in the range 
of the nanometre (nm - 10-9 m) to interact with cells in order to maintain, diagnose or improve 
health (Etheridge et al., 2013; Nie, 2009). Collectively for bioloigical therapeutic use; this 
arena has been termed nanomedicine – nanotechnology, biology and medicine (Bharali et al., 
2013; Mason and Dunnill, 2008). These include but are not limited to peptoid nanosheets  
(Morgani et al., 2013), nanocrystals (nanoparticles/quantum dots) (Cauffman et al., 2009; 
Cifarelli et al., 2013) and carbon nanotubes (Mintz et al., 1984) for drug delivery and 
diagnostics. 
 
Traditionally the definition of nanotechnology has been limited to the range of 1-100 nm as 
described by the National Nanotechnology Initiative,  a US federal government enterprise for 
the advancement of nanoscale research (Goldfarb and Morgan, 2013; National Research 
Council (U.S.). Committee to Review the National Nanotechnology Initiative. and National 
Academy Press (U.S.), 2006). At that scale we observe quantum restriction taking hold and 
the properties of compounds favourably being altered compared to their macroscale. For 
example much more refined absorption and emission spectra (Allan and Delerue, 2005; 
Larson et al., 2003) and increased physiochemical interaction and bioavailability of 
nanocrystals (Van Eerdenbrugh et al., 2008). However in the range above 100 nm, we observe 
the Plasmon-resonance (the frequency at which photons match the resonance frequency of 
surface electrons in a nanoparticle) and this phenomena is being assessed in clinical trials 
using gold nanoparticles at 150 nm to thermally treat tumours (Etheridge et al., 2013).  
 
Liposomes and nanoparticles around 200 nm also show beneficial in vivo persistence in blood 
plasma and the passive targeting of specific in vivo sites using the enhanced permeability and 
retention effect (EPR) (Litzinger et al., 1994) with particles in the range of 400 nm proving to 
have favourable specificity (extravasation) for tumour tissue (O'Neal et al., 2004) . We also 
observe conjugated quantum dots/nanoparticles being designed with payloads, (streptavidin 
and specific antibodies) being able to interact with cells on a genetic level through 
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short-interfering RNA (siRNA) (Yezhelyev et al., 2008) as well as active cancer (Wu et al., 
2003) and neural tissue targeting (Vu et al., 2005). Although of great promise, much work 
still remains to characterise toxicity; pharmacodynamics and pharmacokinetics of these 
nanoparticles and devices in vivo (Karin and Mintz, 1981; van der Kamp et al., 1984).  
 
Noteworthy is the ambition in bionanotechnology to create nanomachines by the year 2025. It 
is envisaged that these nanomachines will possess ‘theranostic ability’ i.e. have the combined 
capacity of therapy and diagnostics all in one nano-device (Hauptman A, 2005). 
 
 1.4    The stem cell  
The stem cell is the focal point of most modern tissue engineering approaches and it can be 
described as a cell which has the ability to self renew and has clonogenic properties, i.e. one 
parent stem cell has the capacity to proliferate and give rise to an entire colony of daughter 
cells (Lanza, 2006). They can also do this and remain undifferentiated after several cycles of 
cell division (by symmetric as well as asymmetric cell division). Finally, they can also be 
described as being potent i.e. are able to differentiate into the different cells which make up an 
organism (through asymmetric division). The potency of a cell can be categorised by the 
degree of its differentiation ability (Gomez-Lopez et al., 2014). During the development of a 
human being stem cells eventually give rise to all the organs and systems of the body, as 
shown diagrammatically in (Figure 1.1).  
 
The different stem cell potencies include a totipotent cell which is a zygote or fertilised ovum 
divided up to the 8-16 cell stage of the morula, these cells are truly able to form any cell 
which makes up an organism including cells of the placenta (Surani and Tischler, 2012).  The 
pluripotent stem cells of a blastocyst/embryoblast (comprising of 70-120 cells) has the power 
to later form into any of the three germ layers which make up a very early stage embryo and 
goes on to form an entire organism. They include the endoderm or interior embryo which later 
gives rise to the stomach lining, gastrointestinal tract, and lungs etc; the mesoderm, the mid 
layer of cells which forms the muscle, bone, blood, urogenitalia of an organism and the 
ectoderm which later forms epidermal tissues and the nervous system. These cells fall short of 
the term totipotent as they lack the power to form extra-embryonic tissue such as the placenta 
and the umbilical cord. The ability of stem cells from one germ layer e.g. the mesoderm to 
give rise to cells which originate from a separate germ layer e.g. liver or lung tissue which 
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usually originate from the endoderm is referred to as plasticity or transdifferentiation (Krause 
et al., 2001). The plurioptent cells which were discussed in the last sentence are generally 
referred to as embryonic stem cells (ESC), and reprogrammed cells such as induced 
pluripotent stem cells which will be discussed later in more detail.  
 
Multipotent cells or progenitor cells can differentiate into several different types of cells, 
however they begin to commit to particular lineages e.g. stromal, circulatory or neural tissues 
and the progenitor cells lack the capacity of unlimited self renewal as is the case with ESC. 
Bipotency is the ability of progenitor cells to differentiate only into a few different cell types, 
due to an increased level of lineage commitment compared to multipotent cells. These can 
include the epithelial stem cells of the mammary glands which have the potency to give rise to 
myoepithelial and luminal cells (Hassiotou et al., 2013).  Finally, there are unipotent cells 
such as spermatogonial stem cells (De Rooij and Griswold, 2012) which are referred to as 
blast or precursor cells, these cells can only form one cell type. In an adult organism stem cell 
differentiation is usually restricted by particular lineages or their tissue environment and do 
not usually display greater differentiation prowess than multipotency.  
 
The fact that harnessing the power of the stem cell has the potential to provide almost 
limitless regeneration of any tissue from almost any injury is indeed revolutionary as at the 
beginning of the 20th century this notion would have been thought of as impossible 
(Chistiakov, 2012; Kuwabara and Asashima, 2012; Teo and Vallier, 2010). Certain 
difficulties such as control of stem cell renewal and differentiation must first be overcome 
however before the true promise of tissue engineering can be realised. Due to the fact that the 
most regenerative potential is promised from multipotent and pluripotent stem cells, and the 
majority of research and clinical trials is performed using them, these two types of stem cells 
will be elaborated upon in more detail. 
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 Figure 1.1: Developmental origins of the human organism and the presence of stem cells 
of different potencies along that development spawning from the embryonic ectoderm, 
endoderm and mesoderm, with permission from publisher (Mimeault et al., 2007). 
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1.4.1    Multipotent stem cells  
The term covers adult autologous stem cells which can be isolated from most tissues in the 
body. Their differentiation capability is limited to lineages associated with the tissues or 
organs in which they take up residence, although there are now papers published proving 
multipotent stem cell plasticity (Conese et al., 2014; Zhang and Alexanian, 2014). Generally 
their occurrence in a specific tissue is approximately 1 in 10,000 cells, a limiting factor in 
their therapeutic use (Hipp and Atala, 2008). At present the vast amount of research and 
clinical trials that involve multipotent stem cells, use either mesenchymal stem cells (MSCs) 
or haematopoietic stem cells (HSCs). 
 
1.4.1.1    Mesenchymal stem cells  
Mesenchymal stem cells were first described by Friedenstein et al in the sixties as cells which 
could form colonies with a fibroblastic appearance, and hence they were first designated as 
colony-forming unit-fibroblasts (CFU-Fs) (Friedenstein et al., 1968).  Since then there has 
been some controversy as to the precise origin of MSCs and although for the most part it is 
agreed and was first published that they originate from the mesodermal layer (Caplan, 1991, 
1994) work since then also suggests that the neuroepithelium may play a role in MSC origin 
(Takashima et al., 2007)  and indeed this notion may be given credence by papers which state 
that MSCs are a heterogeneous population of cells which also show plasticity in their ability 
to form somatic cells from the ectodermic germ layer (Taran et al., 2014; Zhang and 
Alexanian, 2014). Further research also suggests that MSCs are also related to pericytes and 
that their true niche is perivascular (within small indentation/fenestrations on sinusoidal 
capillaries) and the resulting loss of stemness and efficacy in vitro after each passage is due to 
the loss of this perivascular environment (Crisan et al., 2008).  
 
MSCs have now been characterised using three main criteria issued by the International 
Society of Cellular Therapy. They can be isolated due to their affinity for plastic, they express 
specific phenotypic markers; CD-73, CD-90, CD-105, STRO-1 and more recently 
CD-271(Etheridge et al., 2013) and lack expression of CD-45, CD-34, CD-14, CD-11b, 
CD-79, and HLA-DR which is a leukocyte antigen (MHC class II cell surface receptor). 
Finally they have the potency to differentiate into mesenchymal lineages namely osteoblasts, 
adipocytes and chondrocytes (Dominici et al., 2006) .   
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Further to these three criteria MSCs also have immunomodulating/anti-inflammatory 
(Krampera et al., 2006; Sharma et al., 2014)  and immunosuppressive (Ren et al., 2011; Su et 
al., 2014) ability (paracrine properties –  expression of nitric oxide, indoleamine 
2,3-dioxygenase, IL-6 for example), both on the innate and adaptive immune system, as well 
as being proangiogenic and antiapoptotic (Nascimento et al., 2014). It is thought that a further 
benefit of using allogeneic MSCs is a lower level of expression of major histocompatibility 
complex (MHC) related antigens (hypoimmunogenic) compared to somatic cells, furthermore 
novel research suggests that improved therapeutic efficacy can be gained by matching MHC 
in allogeneic MSCs, reducing donor specific T-cell and B-cell response (Lee et al., 2014; 
Schu et al., 2012). 
 
MSCs possess the capacity to home to a site of injury by responding to chemokines/ 
proinflammatory cytokines (IFN-γ, TNF-α, IL-1α) released by injured cells (Krampera et al., 
2006; Spaeth et al., 2008) subsequently overseeing the repair process (Phinney and Prockop, 
2007). They are also characterised as having further regulatory and supportive effects on 
hematopoietic stem cells both ex vivo (proliferation, maintenance of stem cell viability) 
(Dewey et al., 1977; Krikorian and Steward, 1978) and in vivo (e.g. RANK ligand production 
/osteoclast formation) while not becoming hematopoietic in their natural state (Dewey et al., 
1978).  
Although we now understand that MSCs are present in all adult and fetal tissues in the 
vasculature as part of the pericyte population (Crisan et al., 2008); as far as harvesting a 
sufficient number of adult MSCs for expansion and implementation in regenerative medicine 
the main sources remain the bone marrow stroma and adipose tissue although other potential 
candidates include the blood, dental pulp cavity, placenta, cord blood/wharton’s jelly and 
amniotic fluid, (Pappa and Anagnou, 2009; Pozzobon et al., 2013). 
 
Research suggests that both adipose derived (AD-MSCs) and bone marrow derived 
mesenchymal (BM-MSCs) stem cells have comparable properties in most parameters such as 
clonogenecity, proliferation rate and differentiation potential, but differ with the presence of 
certain surface markers, for example BM-MSCs show an increased expression of CD-146 and 
AD-MSCs are positive for CD-34 and CD-54 which are not present in BM-MSCs (De Ugarte 
et al., 2003b; Zhu et al., 2012b). That being said however after in vitro culturing AD-MSCs 
quickly loose this CD-34 surface mark (Maumus et al., 2011; Sengenes et al., 2005). Also of 
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note, in vitro passaging of BM-MSCs begun to show features of senescence (loss of cell 
viability) in almost half the time as AD-MSC, and the use of serum added media can also alter 
MSCs characteristics (Dmitrieva et al., 2012b).  
 
Another favourable trait of MSCs as a regenerative tool is their ability to release bioactive 
factors (trophic properties) which affect neighbouring cells indirectly and directly, while 
themselves remaining undifferentiated by this process (Shabbir et al., 2010; Shabbir et al., 
2009). In the trophic properties too we observe differences in secretion levels of MSCs with 
BM-MSCs showing a higher level of expression of vascular  endothelial growth factor 
(VEGF), stromal cell-derived factor-1 (SDF-1) and transforming growth factors/bone 
morphogenetic protein-2 (TGF-β/Bmp2) compared to AD-MSCs (Dmitrieva et al., 2012b). 
Interestingly, as well as all of these attributes new data is also coming to light which suggests 
that MSCs may also have the benefits of an analgesic (Pang et al., 2014).  
 
MSCs will be paramount for the future pursuits of regenerative medicine and immune 
disorders and this is helped all the more by the fact that good manufacturing practices (GMP) 
for on scale clinical-grade production are coming into main stream use in line with the 
regulatory bodies such as the US Food and Drug Administration (FDA) and in Europe under 
Commission Directive 2003/94/EC (Sensebe et al., 2011; Sensebe et al., 2013). Despite these 
achievements a lasting hurdle which remains in the clinical translation of a MSCs treatment is 
the heterogeneity of results from different batches of cells in different patients, 
notwithstanding the need for serum free media and the secondary effects different batches of 
FBS may also confer on MSCs. Here too steps are being made, in finding novel specific 
surface markers such as Tumour necrosis factor-inducible gene 6 protein (TSG-6) , which 
inhibit inflammatory responses in microglial cells (Song et al., 2014) and syndecan 2 CD-362, 
recently discovered by Orbsen Therapeutics, which also appears to confer immunosuppressive 
wound healing qualities to MSCs (Vlashi and Pajonk, 2014). The expediency of these novel 
markers suggests that they do not only characterise the presence of a MSC for clinical use, but 
that they also begin to give some information into the potential efficacy which may be 
observed in future clinical trials using MSCs for therapy. 
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1.4.1.1.1   The osteoblast 
Critical to this body of research has been the MSCs potency to be able to differentiate into 
osteoblastic cells; a process referred to as osteogenesis or osteoblastogenesis in the literature 
(Xie et al., 2014). A key function of osteoblasts is the secretion of osteocalcin (OCN) which is 
an extracellular (calcium binding) mineralisation protein (Lee et al., 2007). Osteopontin is 
another calcium binding extracellular matrix glycoprotein secreted by osteoblasts, which also 
expresses a specific amino acid sequence (arginine, glycine, aspartic acid - RGD ligands)  
facilitating cellular adhesion through integrin attachment (Bautista et al., 1994; Zou et al., 
2013).  The up-regulation of these key mRNA and proteins as well as bone morphogenetic 
protein 2 (Bmp2),  osteonectin, alkaline phosphatise (ALKP),  runt-related transcription factor 
2 (RUNX2), and its effector also an osteogenic transcription factor; osterix (Matsubara et al., 
2008) is accepted as validation of MSC differentiation into osteoblasts (McNamara et al., 
2010; Nikukar et al., 2013).  
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Figure 1.2: Diagram showing (A) cross sectional framework of bone and (B) the interplay 
between osteoblasts, osteoclasts and osteocytes. Figure reproduced with modification from 
(A) nature article (Taylor et al., 2007) and (B) nature article (Sims and Martin, 2014). With 
permission from the publisher. 
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The osteoblast can further be characterised by responding to the presence of parathyroid 
hormone (cyclic adenosine monophosphate (cAMP pathway) for calcium homeostasis, the 
production of alkaline phosphatase for ECM modulation (Ozaki et al., 2005) and the secretion 
of Collagen I, which comprises 90% of the organic nature of bone (Wildemann et al., 2004). 
Osteoblasts do not only respond to mediating factors but also have a autocrine/paracrine effect 
in facilitating the regulation of skeletal tissue and cells, and to that end release cytokines 
(IL-6, osteoprotegerin, TNF-α RANKL)(Gowen et al., 1990; Ishimi et al., 1990; Steeve et al., 
2004) and growth factors (VEGF and TGF-β) (Liu et al., 2012; Robey et al., 1987; Spector et 
al., 2001). 
 
The osteoblast, along with the osteoclast and osteocyte are the cells which model bone, as 
represented in (Figure 1.2). While the osteoblast synthesise hydroxyapatite, forming matrix 
mineralisation (initial formation of an osteoid), the osteoclast (formed from a hematopoietic 
lineage) carry out resorption. The osteocytes are formed from osteoblast after being cemented 
into matrix and reside in lacuna. They are connected to osteoblasts and osteoclasts through 
channels called canaliculi, and are thought to have a regulatory designation (Bonewald, 2007). 
It is suggested that the osteocytes interpret mechanical stimulation by a differing mechanism 
compared to osteoblasts, i.e. through the cell body or dendritic processes instead of through 
the filapodia or polygonal protrusions  and the signal is mediated through gap junctions and 
hemichannels resulting in the release of signalling compounds such as prostaglandins into the 
bone fluid (Jiang et al., 2007; Klein-Nulend et al., 2013b). This is unsurprising as it has been 
published that prostaglandins have the effect of not just regulating cyclic AMP levels which is 
important in many cell processes, but also the ability to regulate calcium movement 
(Yamasaki, 1983). 
 
Matrix mineralisation by osteoblasts is a complex process which involves several extracellular 
matrix proteins for cell proliferation (Bmp2,c-Jun,RUNX2), matrix maturation (alkaline 
phosphatase, collagen) and the eventual mineralisation (osteocalcin, osteopontin), i.e. calcium 
phosphate deposition, which occurs after approximately 28 days, as represented by (Figure 
1.3) (Sanchez Alvarado and Yamanaka, 2014; Stein and Lian, 1993). Note c-jun will be 
discussed later in more detail, in reference to the ERK/MAPK pathway. Figure 1.3, only 
provides a guide to the chronological timeline of mineralisation, this would change depending 
on the type of chemical or mechanical stimulation being carried out, nevertheless, the 
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chronological order of genes starting with BMP2 and RUNX2 would for the most part remain 
the same. 
 
 
Figure 1.3: A.) Diagram showing the key osteogenic related proteins involved in 
proliferation, maturation and mineralization of the osseous extracellular matrix in a 
chronological manner dependant on the master transcriptor RUNX2 – upregulated proteins 
shown in green, and down regulated bone sialoprotein (BSP) shown in red. B.) Histological 
representation of proliferation to matrix minerlisation, figure used with permission from the 
publisher (Stein et al., 2004). 
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1.4.1.2    Hematopoietic stem cells  
These multipotent stem cells originate from the mesoderm and reside in the bone marrow 
giving rise to the cells that make up the blood (haematopoiesis); including myeloid (innate 
immunity) and lymphoid (adaptive immunity) progenitors. This capacity makes 
hematopoietic stem cells (HSCs) useful therapeutically in leukemia and immune related 
conditions and subsequently it has been found that umbilical cord blood, which can be 
cryopreserved at birth,  may also be a useful source of HSCs for treatment in later life 
(Stephen J. Szilvassy Albertus W, 2013). Prominent surface marker identifiers of 
hematopoietic stem cells are CD-34, CD-45 and CD-15 (Dominici et al., 2006).  
 
Self renewal and viablility of HSCs in vitro can be maintained by co-culture with primary or 
immortalized stromal cells, i.e. MSCs (Fei et al., 2007) and stromal free expansion can be 
aided by culture with hematopoietic soluble factors such as angiopoietin like proteins 
(Himburg et al., 2010). HSCs are putatively one of the first and hence, best characterised adult 
stem cell (Weissman, 2000) and as a result clinical trials are now underway to treat conditions 
such as critical limb ischemia/arterial disease, being pioneered by commercial firms such as 
Aastrom Scientific (Kondo et al., 2003; Ledford et al., 2013; Powell et al., 2011).  
 
They also show therapeutic promise for use in patients who may have undergone high dose 
irradiation, as would have been observed, for example in the Chernobyl disaster (Bishop, 
1997). This type of therapeutic capacity is made all the more poignant in light of the more 
recent Fukushima incident.   
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1.4.2    Pluripotent stem cells 
By definition a plurioptent stem cell will form a teratoma if introduced into an organism 
without first undergoing partial differentiation, they require a supportive or feeder layer of 
cells to remain viable in vitro (although research into serum free and feeder free culture is on 
the way (Jungreuthmayer et al., 2009), and they have the potential (ESC) to spontaneously 
form a spheroid mass of cells referred to as an embryoid body.  In the case of ESC they are 
also harvested from the inner cell mass of a developing embryoblast. Furthermore, in humans 
ESC  have an increased expression of E-Cadherin (Kurosawa, 2007), alkaline Phosphatase 
and SSEA-4 as cell surface protein markers (Takahashi et al., 2007) and transcription factors 
Oct-4, Nanog and sox2 which are necessary for the maintenance of their pluripotency (Ling et 
al., 2012) .  
 
While in the past the pluripotent stem cell almost instantly meant ESC; this is no longer 
necessarily the case. Due to ethical concerns and through biological engineering research into 
pluripotent stem cells is now a wide and varied group which will be discussed briefly.  
 
Parthenogenetic embryonic stem cells (pES) involve the derivation of stem cells which have 
solely come from an oocyte which has not undergone fertilisation by male gametes. This 
involves their activation to form a blastocyst through electrofusion and the use of media 
containing activating chemicals (e.g. ethanol) (Kaufman et al., 1983)  or 
dimethylamino-purine (Mai et al., 2007)). pES show promise in the study of diseases e.g. 
some cancers are theorised to be related to imprinting, the silencing of an allele from a 
particular parent in the offspring  (Feinberg et al., 2006) and pES may hence aid in the 
understanding of the regulation of epigenetic imprinting in humans (Hernandez et al., 2003). 
 
Similar to pES, germline-derived pluripotent stem cells (gPS) can be derived from 
reproductive cells, however in this case they would usually be sourced from the 
spermatogonial stem cells which are initially unipotent. It has been published that culture of 
these cells under ES conditions (without splitting, the use of ESC media, and on embryonic 
fibroblast feeder cells), intriguingly facilitates the formation of pluripotent stem cells. These 
cells could have the potential for use in autologous regenerative therapies (Kim et al., 2014; 
Ko et al., 2009).  
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Although being researched to a lesser extent pluripotent stem cells derived through 
therapeutic cloning or somatic cell nuclear transfer (SCNT) also shows promise as another 
therapeutic source of autologous artificially produced pluripotent stem cells (Tachibana et al., 
2013) .  
 
In the use of artificially produced pluripotent stem cells, induced pluripotent stem cells 
(iPSC), are at the forefront of research. Induced pluripotent stem cells were first pioneered by 
Yamanaka for which he received the 2012 Nobel Prize in Medicine. He discovered that 
pluripotency could be induced by the expression of 4 master transcription factors (Oct3/4, 
Sox2, c-Myc, and Klf4) using a viral vector. With culture under ESC conditions they reverted 
differentiated somatic fibroblast cells to a more primordial pluripotent chronological state,” in 
effect biologically winding the clock backwards” (Takahashi and Yamanaka, 2006). Since 
then several different somatic cells including hepatic, blood, epithelial and gastric, have 
shown the width of this technology (Zhou et al., 2012).  
 
Also of note, research using mice has shown that the expression of microRNA (miR-291-3p, 
miR-294 and miR-295) which is specific to ESC also improves the efficiency of iPSC by 
modulating reprogramming by Oct4, Sox2 and Klf4. Interestingly, these microRNA are 
promoted by c-Myc suggesting that it is a downstream effector of the c-Myc transcription 
factor (Judson et al., 2009). 
 
As c-Myc and Klf4 are known to be oncogenic, research has shown that iPSC can be formed 
without these transcription factors (Huangfu et al., 2008). Considering the use of a virus and 
stimulation of potential oncogenes would certainly pose pharmaceutical regulatory questions  
in their own right, it is significant that Zhou and his colleagues have been able to form what 
has been termed protein-induced pluripotent stem cells (proteins introduced into the cells via 
poly-arginine anchors (Zhou et al., 2009)). Further to this the use of small compounds which 
mimic the effect of transcription factors  such as valproic acid (Huangfu et al., 2008) and 
Thiazovivin (Lin et al., 2009) have also been shown to improve the reprogramming efficiency 
of the process 100 and 200 fold respectively, compared to Yamanaka’s original process.  
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In 2014 the first human clinical trials using autologous iPSC was initiated in Kobe Japan by 
the Ministry of Health, for treatment in age-related macular degeneration (RikenCenter, 
2013). 
 
1.5    Stem cell differentiation 
In vivo it has been found that natural microenvironments (niches) are used to orchestrate the 
life and phenotype of the stem cell dictating whether it maintains homeostasis, (a state of 
inactivation yet maintaining genetic and biological viability known as quiescence) whether it 
begins to self-renew, migrates to new locations or differentiates into specific tissue to aid 
regeneration (Dmitrieva et al., 2012b; Kshitiz et al., 2012). A key component which creates a 
microenvironment from which the stem cell receives the instructions which governs its role; 
includes the ECM such as collagen, laminin, fibronectin and proteogylcans. This is coupled 
with respective naturally occurring cell mediating compounds (e.g. cytokines, growth factors, 
hormones) specific for the type of lineage tissue or cell to be formed (Schmeckebier et al., 
2013; Yu et al., 2012; Zolochevska et al., 2012), as well as mechanical cues described as 
mechanotransduction  and nano-stimulation (Dalby et al., 2014b), and oxygen tension 
(Pimton.P, 2013). 
 
It is now thought that the fate of stem cells (including changes between different potencies 
during development), are not just due to information from their base genetic sequence 
(genotype),  but is also orchestrated through epigenetic cues such as DNA methylation, 
messenger RNA (mRNA) methylation, histone modification /acetylation, and the resultant 
changes in the expression levels of microRNA (Guo et al., 2014).  
In vitro experimentation with biomaterials seek to mimic these physical environments found 
in vivo to interact with cell surface receptors for intracellular signalling, gene expression and 
adhesion in order to regulate cell function. Of particular relevance to this body of work and to 
this thesis is the process of osteogenesis. The process of  osteogenesis has been induced in 
MSCs through several mechanisms including nanotopography described in seminal papers 
from Dalby et al. (Dalby et al., 2007b; Dalby et al., 2007c; Dalby et al., 2006a; Dalby et al., 
2006b), geometrical manipulations (Kilian et al., 2010; McBeath et al., 2004), hydrostatic 
pressure or fluid shear stress (Henstock et al., 2013; Liu et al., 2009a; Liu et al., 2009b), 
parathyroid hormone and transforming growth factors (TGF) (Yu et al., 2012), ambient 
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hydrogel stiffness (Engler et al., 2006), pulsed electromagnetic field stimulation (Cronmiller 
and Mintz, 1978) and hypergravity (Kacena et al., 2004; Prodanov et al., 2013). Surfaces with 
a high (biological) Young’s modulus (40 kPa) and nano-patterns in elaborate formations 
facilitate the development of large focal adhesions bringing about up-regulation in the 
G-protein RhoA and the ROCK (RhoA kinase) pathway. As a result of this the actin 
cytoskeletal is fortified through phosphorylation increasing the cytoskeletal tensile strength 
that is required to support the large osteoblastic cells; the resultant cell type of osteogenesis 
(del Rio et al., 2009; Sawada et al., 2006; Vogel and Sheetz, 2006). This process also 
facilitates cell motility with actin (contractility through RhoA) and myosin working in tandem 
with integrin containing micro protrusions known as filopodia locating attachment sites 
(Miller et al., 2014).  
1.5.1   Mechanotransduction 
The process by which mechanical forces occurring extracellularly are perceived and 
interpreted by biologically active cells, resulting in intracellular (nuclear deformation) 
changes; facilitating adaptation to these mechanical changes in their environment is referred 
to as direct mechanotransduction. Indirect mechanotransduction would be brought about 
through biochemical stimulation and the two very often can work in tandem (Dalby, 2005).  
The physical antennae which senses these changes and can respond by clustering are the 
integrins (heterodimer α and β subunit transmembrane receptor) and they are physically 
attached to a specific amino acid sequence (RGD ligand) found on extracellular matrix 
proteins like OPN and fibronectin. On the opposing end of these integrin transmembrane 
receptor are protein complexes (paxillin, vinculin, talin) which form focal adhesions 
intracellularly. These focal adhesion complexes interact and can regulate focal adhesion 
kinase/Src (or protein tyrosine kinase), and are also attached to the cell cytoskeleton via 
F-actin, (Figure 1.5).  
F and α- actin dictate the physical structure or shape, integrity and motility of the cell (actin 
microfilaments) along with tubulin (microtubules). In the mechanotransductive flow, the actin 
cytoskeleton also comes into contact with the lamin nucleoskeleton (intermediate filaments) 
through linkers of nucleuskeleton and cytoskeleton (LINC) complexes. The nucleoskeleton 
interacts with chromosomes (telomeres) mechanically influencing their repositioning and as a 
result, gene transcription (Ostlund et al., 2009).  
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Hence, focal adhesions can instigate a mechanistic cascade which downstream can cause the 
up-regulation in transcription factors responsible for self-renewal, migration, or differentiation 
(adipogenesis or osteogenesis (phosphorelated RUNX2), see (Figure 1.4 and Figure 1.5) for 
a diagrammatic representation of the mechanotransductive flow believed to be involved in 
nanokicking which has been described above (Dalby et al., 2014b), (Wang et al., 2009b).  
 
Figure 1.4: Diagrammatic representation of the cell mechanotransduction and the resulting 
differentiation through focal adhesion attachment, cytoskeletal and nuclear/chromosome 
activation.  Figure reproduced with permission from the publisher (Dalby et al., 2014b).  
 
In terms of osteogenesis it has been published that larger well spread focal adhesions (super 
mature or fibriller focal adhesions > 5 µm) can bring about osteoblast differentiation through 
increased cytoskeletal tensegrity, instigated by RhoA (Ras homolog gene family, member A - 
which is a small GTPase protein) mentioned above (Tay et al., 2013). The extent of 
ossification or  mineral deposition during remodelling can be effected by mechanical stimuli 
or weight bearing, which has also been theorised by Wolff’s Law (Klein-Nulend et al., 
2013a).  
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The integrin, focal adhesions, also activate the MAPK extracellular-signal related kinases 
(ERK, chiefly ERK 1/2) by stimulating Ras (similar to RhoA) and the pathway is further 
regulated by p38 MAP kinase (which phosphorylates subsequent mitogenic kinases), and 
c-jun-n-terminal kinase (JNK) which phosphorylates the transcription factor c-jun, to name 
but a few kinases involved. Downstream the ERK/MAPK pathway can also bring about 
osteogenesis (Nikukar et al., 2013; Tsimbouri et al., 2012b).  
 
Fundamentally the loci for the alleles coding for osteogenic related genes can be found on 
larger chromosomes (osteopontin 4q22, alkaline phosphatise 2q37, osteonectin 5q31, 
osteocalcin 1q25-31) which have greater telomeric mechanosensitivity, hence possibly 
facilitating access to these genes by transcription factors promoting the osteoblastic phenotype 
(Tsimbouri et al., 2013). This potentially makes focal adhesions a poignant agonist of 
nanokicking related osteogenesis (Nikukar et al., 2013).  
 
 
Figure 1.5: Mechanostransduction through mechanical stimulation: Potential mechanism of 
the flow of mechanical force (such as high frequency vibrations - nanokicking) originating 
outside of the cell transduced intracellularly causing a physiochemical (and genetic) change 
downstream (Wang et al., 2009b). Used with permission from the publisher. 
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When discussing direct mechanotransduction as well as taking into account the mechanical 
forces, discussed previously, which undoubtedly are a major contributor in a technology like 
nanokicking; it should also be considered that there are other mechanistic routes such as ion 
channels and primary cilia which facilitate the mechanotransductive process. These routes are 
not necessarily mutually exclusive and could potentially work hand in hand. The primary 
cilium is a singular microtubule which protrudes out of the cell like an antenna and is 
restricted in movement. It stands out from apical surfaces from nearly every cell in the body 
(including bone related cells) (Singla V, 2006). Interestingly it has been published that cilia 
have a role as a mechanosensor and could bend under fluid shear stress. The bending of the 
cilia seemed to be directly proportional to the extent at which Ca2+ ions would be taken 
through ion channels. Further work also showed that in bone related cells 
(osteoblast/osteocytes), weight bearing and mechanical stimuli such as pressure and vibration 
was also sensed by the micro cilia and it appeared that this may cause an increase in the 
upregulation of genes related to osteogensis such as OPN and COX2. Further still it was 
observed that the cilia (4-9 µm in length) would deflect and recoil under the application and 
cessation of sub-physiological flow and an oscillatory fluid flow (OFF) which caused an 
upregulation in osteogenic gene expression and may play a part in the overall regulation of 
bone formation and resorption (Malone A, 2007; Lee K, 2010; Hoey D, 2012). Also of note in 
relation to chondrogenesis, Wann and his colleagues showed that primary cilia has a critical 
role in the formation of the cartilage ECM and the upregulation in its synthesis. It was found 
that the primary cilia also had the functional ability to induce Ca2+ signalling mediated 
release: downstream of compression (Wann A, 2012).  
In relation to mechanotransduction it has also been published that mechanically activated ion 
channels appear to be sensors of physical force. Key ion channels of note which have been 
published to play a crucial role in ion channel related mechanotransduction include Piezo 1, 
Piezo 2, TREK, TRAAK and TRPN, although there are others (Ranade S, 2015). In osteoblast 
like cells (osteosarcoma cells) there have been observed three classes of mechanosensitive ion 
channels and these could be classed on the basis of conductance,  ion selectivity (in particular 
K+  and Ca+) and sensitivity to membrane tension, and it is thought that these can 
orchestrating a physiological response in bone through mechanical loading (Davidson R, 
1990).  
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1.5.2   Nanotopography and vibrational stimulation 
Very interesting research from the Centre for Cell Engineering in Glasgow has endeavoured 
to assess the use of nanotopographies and to interrogate the possible effect various patterns 
may have on MSCs.  
They have embossed 120 nm diameter and 100 nm deep nanopits into PMMA over 1 cm2 , 
using electron beam lithography. Five different patterns were investigated as a substrate 
platform for stem cell growth, and all had absolute or average centre-centre spacing of 300 
nm.  
The patterns assessed included a square array, hexagonal array, disordered square array with 
nanopits displaced randomly by up to 50 nm, (i.e. the NSq-50), the same again but with 20 
nm displacements (i.e. NSq-20), and nanopits placed randomly over a 150 um by 150 um 
field, repeated to fill the 1 cm2 area. A simple planar surface was used as a control. The cells 
were grown on these different topographies over a 21 day period followed by staining for 
expression of bone specific ECM proteins; osteopontin and osteocalcin, see (Figure 1.6) for 
the results obtained from the work. Further assessments also included a 28 day Alizarin red 
staining for calcium, and a qRT-PCR determination for osteospecific genes. In subsequent 
tests dexamethasone was utilised as a corticosteroid that induced bone formation; and was 
used as an osteogenic media sample (OSM) or positive control (Dalby et al., 2007d).  
The results showed that highly ordered nantopographies, such as square and hexagonal array 
gave negligible osteblastic differentiation and reduced cell numbers compared to the control 
(especially on the hexagonal pattern). The cells on a more random topography, such as 
NSq-50 actually differentiated as far as to give bone nodule formation. The random nanopits 
showed the development of good cell populations but with low expression of osteopontin and 
osteocalcin proving osteogenesis to a lesser extent than the NSq-50 topography (Dalby et al., 
2007d) .   It was theorised that a great deal of the differentiation or lack thereof observed on 
the different topographies could have been attributed to the type and distance of the focal 
adhesions the MSCs were able to attain. This as a result, directly affected cytoskeletal tension 
and mechanotransductive pathways which may have an effect on chromosome positioning 
during cell division and subsequently gene expression (Dalby et al., 2007a; Engler et al., 
2004; Wang et al., 2012; Wingate et al., 2012).  
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Figure 1.6: Showing the different types of nanotpograhical patterns and their osteogenic 
effect on cultures MSCs after 21 days, staing for OPN and OCN, without the use of OSM. 
From left to right, a square array, hexagonal array, disordered square array with nanopits 
displaced randomly by up to 50 nm, (i.e. the NSq-50), the same again but with 20 nm 
displacements (i.e. NSq-20), and nanopits placed randomly. With permission from M.Dalby 
(Dalby et al 2007d). 
As well as facilitating differentiation further work also suggested that certain surfaces can 
help maintain self renewal and hence maintain a viable stem cell population. By reducing the 
level of offset to as close to zero as possible and forming an absolute square lattice symmetry; 
there was a resultant switch from osteogenic differentiation to a surface conducive to MSCs 
growth and replication. This was shown to be the case over an 8 week period, while the 
NSq-50 and OSM samples showed osteogenic induction strongly. The planar 
polycaprolactoen (PCL) surface gave a mixed population of MSCs and differentiated cells 
(McMurray et al., 2011). 
Recent work by D. Pre and his co-workers also proved that low amplitude high frequency (30 
Hz) vibrational treatment was also able to induce adipose derived stem cells to differentiate 
into osteoblasts after as little as 14 days with stimulation. Compared to controls which did not 
undergo mechanical vibration the level of key bone matrix proteins such as collagen, 
osteopontin, bonesialoprotein and fibronectin were found to be increased as much as 10 fold 
when assessed by qRT-PCR and ELISA (Pre et al., 2011b). Further to this, Curtis et al also 
showed that nanoscale vibrations within the region of 1 – 50 Hz implemented by a piezo 
actuator (a device which converts electrical energy to mechanical energy) to endothelial cells 
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were able to up-regulate the expression of endothelin-1 and Kruppel-like factor 2 and 
subsequently increase cell adhesion (Curtis et al., 2013b). 
Lau et al found that low magnitude high frequency vibrations (LMHF) in vitro culture of 
mouse derived MSCs did not have an osteogenic effect, when stimulation was provided 6 x 
over a duration of 1 hour at 0.3 g and 60 Hz. This was carried out over a 2 week period. It was 
hypothesised that this stimulation was not for a long enough duration or at a high enough 
frequency (Lau et al., 2011). Stimulation at 200 Hz had been assessed, however osteogenesis 
was not the goal but instead it was to determine the viability of MSCs (observed to be 96%) 
cultured under these conditions (Gaston et al., 2012). Kim et al too attempted LMHF 
vibrations and found an affirmative response to osteogenesis and deemed that the success of 
the experiment was dependant on the culture method. 3D cultures showed the most positive 
results through an increased expression of collagen I, osteoprotegerin (decreases expression of 
RANK and hence osteoclasts), and VEGF. Their best results occurred at an acceleration of 
0.3g and vibrations of 30 – 40 Hz (Kim et al., 2012). 
A further seminal and insightful paper from the Centre for Cell Engineering at the University 
of Glasgow also investigated high frequency low amplitude vibrations. They researched the 
effect of even higher vibrational frequencies (1000 Hz) driven by a piezo actuator, to induce 
osteogenesis. These results corroborated the increased effect of focal adhesions and the 
fortification of the actin cytoskeleton for osteoblast differentiation (Nikukar et al., 2013). 
High frequency piezo vibrations also at a frequency of 1000 Hz showed microarray genomic 
changes relating to the cytoskeletal structure and an increased proliferation in adhered mouse 
embryonic fibroblast cells (Ito et al., 2011). These data together give credence to the future 
promise and potential of this technology. 
1.6    Bone tissue engineering 
The need for a ready source of skeletal tissue becomes more apparent as people become 
advanced in age, and a spate of osseous defects becomes more prevalent in the elderly. These 
conditions may include osteoarthritis, osteoporosis and all too often severe breaks and 
fractures due to falls. These conditions are further compounded by the fact that a limited 
skeletal regenerative capacity is observed in the elderly as stem cell population decreases 
(Garvin et al., 2007).  
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At present one of the most common forms of regenerative aid employs the use of donor 
derived bone grafts. These include autologous, allogeneic or xenogeneic/heterologous and 
they all have their failings including donor site morbidity, availability, rejection and cost to 
the healthcare system (Hashimoto et al., 2013). This makes apparent the need and urgency for 
successful bone tissue engineering (bone TE) protocols. Bone TE approaches can either take 
the form of cell only (regenerative cells), cell free (osteoinductive constructs) or a 
combination of the two (Bueno and Glowacki, 2009). 
A combined engineering approach  first requires a source of regenerative skeletal cells which 
would very likely be MSCs, and as discussed in section 1.4.1.1, these could be patient specific 
and sourced from adipose tissue, bone marrow or even the blood (Pozzobon et al., 2013). 
However, one of the limitations of MSCs is their replicative senescence when cultured in vitro 
/ ex vivo, and to that effect the use of human telomerase reverse transcriptase (hTERT) 
ectopically expressed has been shown to increase their longevity (Bjerre et al., 2011).  
For successful tissue engineering these cells also require a complimentary extracellular matrix 
for seeding, proliferation and expansion, i.e. scaffolds or polymer coatings with conducive 
physiochemical and mechanical attributes which may also be biodegradable (collagen, 
hyaluronic acid, alginate) (Stevens, 2008). This matrix would further expedite the delivery of 
the MSCs or even more favourably differentiated osteoblasts to the site of damage for 
regeneration and remodelling. Apart from these scaffolds, also of note has been the use of 
demineralised bone matrix as well as bioactivated glass (Schepers et al., 1991).  
It has been published that these scaffolds would be required to induce an osteoblastic 
phenotype or be osteoconductive, to that end, osteoinductive 3D scaffolds (silicates, calcium 
phosphates, calcium carbonates, hydroxyapatite constructs) which can simulate the in vivo 
skeletal environment have been investigated (Bjerre et al., 2011; Wang et al., 2009a).  These 
would of course be more expensive, time consuming and would cause discomfort to the 
patient hence why the introduction of a biodegradable 3D scaffold with differentiated 
osteoblasts would be far more favourable and expedient to the healing process. Osteogenic 
scaffolds would also be required to have sufficient gaseous exchange, supply of nutrients and 
waste removal for long term culture, approximately 28 days (Figure 1.3). The added attribute 
of having osteogenic and/or vascular trophic (rhBMP2, VEGF) ability (Kanczler et al., 2010) 
or an environment that would shift the biochemical gradients away from resorption (addition 
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of bisphosphonates to induce downregulation in osteoclasts) is also desirable (Bobyn et al., 
2009). 
In an attempt to meet the clinical demand for osseous tissue, specific bioreactors for bone 
tissue engineering, (with the aim of providing autologous in vitro/ex vivo engineered grafts) 
have been investigated. The extent of the technology to date will now be considered. 
1.6.1  Bone bioreactors 
Bioreactors for the seeding, expansion and differentiation of MSCs into an osteoblastic 
lineage can be divided into various types. These systems which involve the induction of a 
hydrodynamic stress (shear force) would include perfusion bioreactors and those that employ 
centrifugal force would include a spinner flask and rotating bioreactors. Apart from the three 
bioreactors mention in the last sentence, less well lauded systems entail the use of mechanical 
stimulation (bending, contraction, stretching, compression) and pulsed electromagnetic fields 
(PEMF). Interestingly, since bone is piezoelectric, mechanical deformations can generate an 
electric potential (Bjerre et al., 2011), what’s more bone appears to have a selective EMF 
frequency of approximately 15 Hz which also appears to be osteogenically effective. It is 
noteworthy that to date some successes have been observed from the perfusion bioreactors. 
These employ the use of the flow of the media or fluid over cells for the movement of nutrient 
and gaseous diffusion. Further to this some success has also been attained through shear 
stress. The perfusion bioreactor will be briefly discussed in section 1.6.1.3 (Rath et al., 2012; 
Yeatts et al., 2013).  
1.6.1.1    Spinner flask bioreactors 
The spinner flask utilises convection currents which are generated by a magnetic stirrer at the 
bottom of the flask. This design can make use of cells seeded on a 3D scaffold (e.g collagen 
and silk) (Korin et al., 2009), attached to a needle like apparatus protruding from the top, and 
passing through its centre with the cells and 3D construct being stimulated by the flowing 
medium. This can be altered by varying the speed of the magnetic stirrer. Oxygen is allowed 
to diffuse through the bioreactor by the use of filtered angled side arms, preventing 
contamination. The entire unit is intended to be kept at optimum environmental conditions by 
using an incubator.  
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Published work has reported an affirmative osteogenic effect by an early up-regulation in the 
ALKP maker in human MSCs, where a stirring velocity of 50 rpm was employed. An 
increase in proliferation and osteogenic marker genes was observed relative to static controls 
(Korin et al., 2009). A further stated positive of this bioreactor design is that it is relatively 
inexpensive compared to others which will be discussed in this section and what’s more it can 
be used for dynamic seeding (Wang et al., 2013). That being said however, a shortcoming of 
the use of 3D constructs with the spinner flask is the formation of more and less dense areas 
of cells which can impede gaseous and nutrient transfer in varying regions (particularly the 
centre) of the scaffold. Furthermore, it has also been noted by users of the spinner flask that 
this design lends itself to varying convection current gradients, with lager convection forces 
being found at the bottom of the flask in closer proximity to the magnetic stirrer bar (Bjerre et 
al., 2011). This may have a varying osteogenic effect at different regions. 
1.6.1.2  Rotating bioreactor 
The origins of the design of this bioreactor can be found in the rotating wall vessel 
implemented by the National Aeronautics and Space Administration for the simulation of 
microgravity conditions (Bjerre et al., 2008). In this bioreactor we observe the use of dynamic 
shear stress, (created by laminar flow) for the successful diffusion of nutrients, oxygen and 
waste products along a horizontal axis. Different designs have also been used with some using 
discs rotating in a horizontal position to create a shear force; in this case the cells were seeded 
upon these discs (3D constructs). Other derivative designs have utilised the attachment of 
scaffolds to the outer vessel wall in a free-fall and uniform manner, i.e. the rotating wall and 
rotating bed bioreactors.  
Using the rotating bioreactor Pollack and his colleagues published that they observed an 
up-regulation of ALKP as well as an augmented effect for maturation and mineralisation of 
the ECM when contrasted against static controls (Pollack et al., 2000). Using a rotating wall 
vessel bioreactor, Song too also saw an affirmative result for the expansion of 
osteoprogenitors (Song et al., 2013).  
However mixed results using the rotating bioreactor have been published as Goldstein et al 
have reported seeing a decrease in ALKP levels and no change for osteocalcin using precisely 
the same model as Pollack (Goldstein et al., 2001). This negative result was further reasserted 
by Sikavitsas and his co-workers who also saw decreased levels of calcium and ALKP when 
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using a rotating wall vessel system (Sikavitsas et al., 2002). Interestingly, the rotating bed 
bioreactor designed and developed by Zellwerk GmbH, was not only found to provide 
osteoblastic differentiation but was also built with GMP compliance in mind (Anton et al., 
2008).  
Disadvantages of the rotating wall vessel bioreactor include unwanted traction between the 
scaffolds and vessel walls which may result in the destruction of the scaffold and damage to 
proliferating cells, that being said however, this limitation could be overcome by using the 
rotating bed design of the bioreactor. An overall failing though of the rotating design is that 
an osteogenic effect generally seems to be limited to the outside of the scaffold and resistance 
issues to mass (nutrient) transport to  internal sections of the scaffold may be observed 
(Sikavitsas et al., 2002). 
1.6.1.3    Perfusion based bioreactor 
This design of bioreactor implements the use of laminar media flow for gaseous exchange and 
nutrient transport. The system comprises of a central container or cartridge which houses the 
cells and scaffold set up, with medium pumped through the construct via a peristaltic roller. 
Oxygen, gaseous transfer and renewal can either be transitioned through the system provided 
by a reservoir and waste vessel or by implementation of a closed loop system (Fang et al., 
2014).  The perfusion bioreactor laminar flow system can either be separated into direct or an 
indirect design. In indirect systems the central construct and scaffold is loosely sealed which 
facilitates the flow of media in regions of least resistance usually found on the sides of the 
scaffold construct, this design includes commercial bioreactors such as the MINUCELLS and 
MINUTISSUE Vertriebs, (Table 1.1). In direct bioreactor systems however, the setup forces 
the flow of media only through the centre of the cells and scaffold construct, brought about by 
the reduction of limitations which arise from internal mass transfer (Hathout, 2014). It has 
been published that a shear stress of 5 x 10-5 Pa was found to have a positive effect on cell 
proliferation and expansion and that increased shear forces beyond this pressure had an 
increased effect on osteogenic related genes(Deng et al., 2014). It is also noteworthy that the 
commercial OsteoGen perfusion bioreactor (Tissue Growth Technologies (Table 1.1) has 
utilised 3D cultured scaffolds which have delivered positive results ex vivo matrix 
mineralisation, while using micro-computed tomography for online monitoring (Porter et al., 
2007). 
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Disadvantages of the perfusion bioreactor include its complexity for use and set up, and the 
need to scale up the bioreactor in order to engineer clinically relevant sized grafts also provide 
substantial engineering difficulties. What is more it may take several weeks to artificially 
engineer osseous tissue and maintenance of a sterile environment using a complex set up 
during this time may prove challenging (Gardel et al., 2014). The scaffold too; its geometry, 
porosity, dimensions, material make up and potential manufacturing defects will directly 
affect high flow and stresses of the media. This can adversely affecting cell viability, 
proliferation and subsequently mineralisation; not to mention having a deleterious effect on 
biodegradable scaffolds such as collagen (Meinel et al., 2004; Rauh et al., 2011b; Voronov et 
al., 2010). It has also been perceived that another limiting factor to engineered bone grafts 
becoming mainstream is the present cost of bioengineering grafts, which is estimated at 
$10,000 - $15,000; much of which would be due to the cost of building and operating bone 
bioreactors which are presently on the market (Salter et al., 2012).  
Although these bioreactors discussed may work, it appears that cost, complexity and 
maintenance of a sterile environment long term, may limit their use and uptake. This fact 
highlights the prevailing requirement for a cheaper option which can utilise a 3D scaffold, is 
easy to use, can conform to GMP standards and maintain a sterile environment.The most 
important requirement to the modern healthcare system will inevitably be the reduction of the 
overall cost of engineering autologous osseous tissue and or osteoblasts in a 3D matrix, and 
this will be “the make or break” consideration. 
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Company Product Type (Features, options) 
Bellco Biotechnology 
(Vineland, NJ) 
Bell-FlowTM Spinner flask 
Corning® Lifesciences 
(Lowell, MA) 
  ProCulture® glass spinner 
flask 
Spinner flask  
(disposable or autoclavable) 
MINUCELLS and 
MINUTISSUE 
Vertriebs GmbH (Bad 
Abbach, Germany) 
Tissue engineering container Perfusion bioreactor (indirect 
perfusion) 
Tissue Growth 
Technologies 
(Minnetonka) 
OsteoGen Bioreactor Perfusion bioreactor (pulsatile 
fluid flow stimulator, µCT) 
Zellwerk GmbH 
(Oberkrämer, Germany) 
BIOSTAT® Bplus RBS 500 
System, 
Z® RP cell and tissue 
culturing systems 
Rotating bed bioreactor 
(GMP conform) 
Synthecon, Inc. 
(Houston)  
B. Braun Biotech 
International GmnH  
(Melsungen, Germany) 
STLV Bioreactor 
Medistat RBS 
Rotating wall vessel 
Rotating bed bioreactor 
(GMP conform) 
Flexcell International 
Corporation 
(Hillsborough, NC) 
e.g., BioPressTM Compression 
Plates, Fkexcell® FX-5000TM 
Compression System 
Systems using tension, 
compression and shear stress 
GMP - Good Manufacturing Practice; RBS- rotating bed system;  STLV - slow turning 
lateral vessel; µCT - micro-computed tomography. 
 
Table 1.1: Commercially available bone tissue engineering bioreactor systems, 
adapted from (Bjerre et al., 2011; Rauh et al., 2011b). Note this is not an exhaustive 
list, but a guide to some of the other bioreactors which have been developed. 
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1.7    Hypothesis 
It is well known that mesenchymal stem cells derived from the bone marrow have the potency 
to differentiate into osteoblasts, or bone forming cells under given conditions, however much 
work remains to characterise new and efficient means to bring this about. It is hypothesised 
that the new technology in this field of piezo mechanical stimulation, can induce osteogenesis 
in mesenchymal stem cells using high frequency (≥ 1000 Hz) low amplitude (in the 
nanometre range) sinusoidal vertical displacements in 2D, and what’s more there may be a 
potential to augment this effect by complementing it with an osteogenic nanotopographical 
surface, a disordered pattern of nanopits, referred to as an NSq-50. 
It is further hypothesised that these piezo mechanical vibrations can also be transferred in a   
3D environment through a biodegradable scaffold such as collagen I, and hence can also 
provide an osteogenic effect in an environment or extracellular matrix which is biomimetic, 
resembling the osseous condition of the in vivo skeletal framework. This 3D bioreactor would 
have the ability to expand and differentiate MSCs in a GMP sterile environment, would be 
cost effective and would be very easy to maintain and use at the hands of the clinician.  
1.8   Aim 
In the first instance the aim of this PhD was to create and characterise a 2D bioreactor which 
employs high frequency sinusoidal displacements and nanotopographical stimulation as a 
combined mechanical cue to bring about osteogenesis in bone marrow derived mesenchymal 
stem cells. The bioreactors mechanical integrity would first be validated as well as the 
integrity of mesenchymal stem cells to undergo high frequency piezo driven stimulation 
(nanokicking) without deleterious effect. The proof of concept would be determined by 
assessing the transcript (mRNA) and protein landscapes and subsequent mineralisation to 
confirm the presence of calcium phosphate deposition through osteoblast differentiation. This 
aim was then further extrapolated into the development of a 3D bioreactor with the potential 
to engineer ex vivo / in vitro calcium phosphate deposits in a collagen I extracellular matrix in 
a sterile, GMP, cost effective and easy to use manner.
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2.1    Introduction 
In this chapter we begin to examine the construction of a 2D bioreactor which was used to 
induce osteoblastogenesis in mesenchymal stem cells. In order to have confidence in the 
mechanical integrity of the apparatus which had been designed; it was necessary to subject it 
to a rigorous assessment using techniques such as interferometry to determine that the 
displacements, even on the nanoscale, were indeed consistent, reproducible and uniform. The 
questions were further asked; would over heating also be a consequence of high frequency 
vibrations and could the cells respond positively to such high frequencies (≥ 5000 Hz) and not 
undergo adverse effects, i.e. what was referred to as the biological integrity of nanokicking. 
2.2    Piezotechnology and the piezo device 
The piezoelectric phenomenon was first investigated using crystals of boron silicate; 
tourmaline by the Curie brothers back in the late 19th century, when they found that it had 
unique mechano-electrical properties. Simply put a piezo device or piezo actuator is a 
material which has the physical ability to convert mechanical force or deformation into 
electrical energy, or electrical energy into mechanical force. The conversion of mechanical 
force into electrical energy is termed the direct piezoelectric effect, and is caused by the 
crystals physically deforming causing the negative and positive poles found in the polarised 
material to move more closely together. At the same time this allows a charge to move to the 
surface of the material and a potential difference to form between the poles allowing electrons 
to flow. The strength of the charge or the number of electrons that flow is related to the level 
of deformation (pressure applied).  The formation of mechanical deformations from electrical 
energy is termed indirect or reverse piezoelectric effect in which changes in electrical dipoles 
and charge density causes mechanical deformations (Ballato, 1998).  
Both organic and inorganic materials have been found to possess a piezoelectric capacity 
including tourmaline, bone/collagen, tooth/dentine, quartz and even sugarcane. There are also 
artificially prepared ceramics such as barium titanante, which employ lead zirconate titanate 
(LZT) as the piezo active material. Lead zirconate titanate is presently the most commercially 
used material for piezoelectric exploit (Minary-Jolandan and Yu, 2009). For the purposes of 
this body of research use was made of the ability of the piezo actuator to convert electrical 
energy into high frequency low amplitude mechanical displacements in order to vibrate cells 
on an aluminium platform, see (Figure 2.1) for a diagram of the piezo actuator which was 
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used in the 2D bioreactor. Modified LZT and barium titanate was used by the German 
company PI to make the piezo actuators which were utilised for this PhD. These devices had 
resonant frequencies between 200 kHz and 10 MHz which was well above the usable scope of 
this research which hence meant suitability.  
 
 
Figure 2.1: (A) Diagram showing piezo actuator with wire attachments, (B) showing 
magnified view of the piezo actuator device. 
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2.3  Materials and methods 
2.3.1  Materials 
Materials and Reagents Source / Supplier 
Human mesenchymal stem cells, from bone 
marrow 
Promocell GmBH, Germany 
Fetal Bovine Serum (FBS)  Sigma Life Science F9665 
Penicillin streptomycin Centre for Cell Engineering, University of Glasgow 
Versene Centre for Cell Engineering, University of Glasgow 
Trypsin Centre for Cell Engineering, University of Glasgow 
Fixative Centre for Cell Engineering, University of Glasgow 
Ethanol 
(Ethanol:H20/70:30) 
Centre for Cell Engineering, University of Glasgow 
Phosphate buffer saline (PBS)  Centre for Cell Engineering, University of Glasgow 
1% BSA in PBS Centre for Cell Engineering, University of Glasgow 
Rnase free water Qiagen, UK 
Quantitech reverse transcriptase kit Qiagen, UK 
Spectrophotometer Nanodrop ND-1000 
7500 Real time PCR system Applied Biosystems – S/N:275007079 
Dulbeccos modified eagle medium (DMEM) Sigma Aldrich, UK 
Sodium Pyruvate Sigma Life Sciences – S/N: S8636 
Nonessential amino acids Gibco Life Technologies – S/N:11140-035 
Minisart hydrophilic sterile 0.2 µm filters Sartorius Stedim 
Accurepette – pipette gun VWR – AE5453 
Syringes 20 mL & 50 mL BD Plastipak P/N: 300613 & 300866 
Triton X-100 Sigma S/N:T-9284 
Ascorbic Acid Sigma A-7506 
Dexamethasone Sigma D2915-100MG 
Tween 20 Sigma Aldrich P9416-100mL 
Permeability buffer Centre for Cell Engineering, University of Glasgow 
Piezo Actuator Physik Instrumente GmBH Germany  
P/N: P-010.00H 
Thermal IR Detector Thermovision A40 supplied by FLIR systems 
Signal generator Agilent 33210A 
DC offset box Mastech PSU - P/N: HY3003 
Laser Interferometer Vibrometer SIOS Meβtechnik GmBH Germany SP-S120 
 
Table 2.1: Table of materials and reagents used for chapter II 
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2.3.2    NSq-50 polycarbonate substrate fabrication 
A silicon master was utilised to form a permanent impression or imprint on a substrate 
material made out of polycarbonate. The disordered but not random pattern which was 
impressed into the polycarbonate had a near square nanotopographical geometrical pattern of 
pits and was called an NSq-50, see (Figure 2.2C). The imprinting was carried out by the 
process of hot-embossing (i.e. raising the temperature of the polymer substrate, 
polycarbonate, slightly above its glass transition temperature (Tg), but lower than its melting 
temperature (Tm), hence facilitating imprinting). The NSq-50 nanopits were spaced over a 
120 nm diameter; the pits were 100 nm deep with an average centre spacing, which did not 
exceed of 300 ± 50 nm from a perfect square. To serve as a negative control flat surfaced 
polycarbonate substrates which did not have disordered patterns were also fabricated.  
 
2.3.3    Setup of functioning 2D bioreactor  
An Agilent 33210A function generator served as the power source for the piezo actuator from 
being plugged into the mains. Continuous sinusoidal nano-displacements were output by the 
function generator to the petri dish which contained the MSCs. A direct current (DC) voltage 
was provided by a DC offset box i.e. Mastech PSU (part number: HY3003) and this was 
employed to ensure that all voltages would be positive, resulting in a uniform displacement in 
a single direction. The German engineering company Physik Instrumente was used to source 
the piezo actuator device, part number: P-010.00H, as shown in (Figure 2.1). The resulting 
sinusoidal nano-displacements which were introduced into the petri dish were controlled and 
reproducible.  
 
A 20 mm2 polycarbonate substrate, which was either the NSq-50 pattern see (Figure 2.2 C) or 
a flat unpatterned surface (control), was first plasma treated for approximately 20 seconds in 
order to facilitate cell attachment. So as to ensure a physical connection between the 
polycarbonate substrate and the 60 mm diameter polystyrene petri dishes used, 
polycaprolactone beads (FDA approved) were heated on a hot plate to approximately 90ºC 
and served the purpose of a biocompatible adhesive. An aluminium disk (52 mm in diameter 
with a 3 mm thickness) was securely adhered via epoxy to the outer base of the petri dish to 
allow uniform displacement of the entire petri dish. An aluminium block was used as a solid 
support and a stationary foundation onto which the piezo actuator was glued. The aluminium 
block was of dimensions 315 x 100 x 50 mm, and it facilitated the transference of the piezo 
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displacement into the dish instead of out into the ambience. A complete illustration of the 2 D 
piezo bioreactor is provided in (Figure 2.2 A-B).  
 
 
Figure 2.2: Nanokicking vibrational apparatus setup – The 2D bioreactor: (A) cross section 
view of setup showing the petri dish with the aluminium disk and piezo glued to the 
aluminium block which facilitates displacement vertically upwards into the petri dish. (B) 
Aerial view of setup showing the polycarbonate substrate (either NSq-50 or blank surface) 
adhered to the inside of the petri dish using melted polycaprolactone as a rigid biocompatible 
adhesive. (C) Near square disordered nanopits (NSq-50) used as an osteogenic surface for 
MSC differentiation. The nanopits are 120 nm wide and 100 nm deep with an average centre-
centre spacing of 300 nm in a square arrangement, but with up to a ± 50 nm offset in X and Y 
positioning. Figure used with permission from the publisher (Pemberton et al., 2015). 
 
2.3.4    Cell culture and media preparation 
Promocell, Germany was used to source human MSCs. The cells were grown and used for 
culturing in passages 1-3. The basal media which was used to maintain the cells during 
experiments and for proliferation was DMEM (Sigma-Aldrich) supplemented with 10% FBS, 
1% sodium pyruvate - Sigma (11 mg/ml), 1% MEM NEAA – Gibco (amino acids) and 2% 
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antibiotics (6.74 U/mL penicillin-streptomycin, 0.2 µg/mL fungizone). The initial volume of 
the DMEM used was 500 mL and all solutions, save the sterile DMEM, were first filtered 
through a 0.2 µm hydrophilic filter to make the finished basal media.  
 
For the preparation of osteogenic media which served as a positive control, the DMEM basal 
media was also substituted with 100 µMol ascorbic acid and 10 nMol dexamethasone 
(Sigma). For this preparation 0.0088 g ascorbic acid was added to 500 mL basal media. A 
stock of dexamethasone was prepared by adding 0.081 g in 5 mL deionised H2O (41.3 mMol), 
24.2 µL of this stock was added to 1 mL of deionised (1 mMol) and subsequently 5 uL of this 
stock was added to 500 mL basal media (10 nMol).  
 
The population of MSCs used for seeding was approximately 1 × 104 per petri dish, (with 
approximately, 60% of that quantity being seeded on the 2 cm2 polycarbonate flat or NSQ-50 
substrate). All culture was performed in an incubator at 37ºC with 5% CO2, the basal media 
being changed every 2-4 days. 
 
2.3.5    Laser vibrometry and nanokicking bioreactor displacement 
characterisation 
A laser interferometric vibrometer supplied by SIOS Technology Corp. part number: SP-S120 
was used to calibrate individual piezo actuators for accurate nanoscale displacements. For 
reference two individual piezo actuators set up for calibration are shown in (Figure 2.2 B) 
and a diagram of the interferometer, (laser vibrometer) used to perform the measurements is 
shown below in (Figure 2.3).  The piezos were calibrated from 500 Hz to 10000 Hz with a 
varying amplitude range from 2 to 20 volts. A continuous helium neon laser beam at 
wavelength 632.8 nm and at a continuous wave power of 5 mW was shone from the laser 
vibrometer onto the surface of the polycarbonate substrate and was subsequently reflected 
back into the laser vibrometer off a fused silica mirror which was attached to the substrate 
surface.  This reflectance beam created an interference pattern which was then related to a 
reference beam. To align the reflectance beam accurately back into the laser aperture an 
internal oscillating signal was tuned and this was displayed as a resolved circle on the monitor 
of the oscilloscope. INFAS Vibro (Interferometer Analysis Software for Vibrometers) 
computer software supplied by SIOS Meβtechnik GmbH was used to acquire the interference 
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output and convert the information by fast fourier transform; representing it in terms of 
amplitude or displacement in frequency space. The mean of 4 piezo actuators were used to 
determine nanolevel displacement for the different frequencies relative to an increase in 
voltage, see (Figure 2.6 A) for these results. 
 
The calibration of increasing number of piezo actuators connected in series to the same signal 
generator was further assessed to determine if this would have an effect on the displacement 
output, see (Figure 2.6 B) for these results.  
 
 
Figure 2.3: Laser vibrometer used to perform interferometric experiments in order to calibrate the 
bioreactor (displacements were assessed at the nanometre level). A helium neon laser beam is 
shone from the laser vibrometer to the piezo activated surface of the polycarbonate substrate in 
the centre of the petri dish. The laser was reflected from the surface of a statically adhered fused 
silica mirror back into the laser vibrometer to make an interference pattern related to a reference 
beam. The INFAS Vibro, (i.e. the Interference Analysis Software for Vibrometers) was used to 
construe the results. Fast fourier transform (FFT) computer software was used to assign an 
amplitude of the displacement relative to the frequency at a given voltage, vertical resolution = 
0.02 nm. FFT reading was determined approximately every five seconds by the software and five 
readings were also recorded at each voltage for a particular frequency. 
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2.3.6    Thermal assessment  
In order to confirm that at high frequency vibrations the generation of heat would not be an 
issue thermal characterisation was carried out. Infrared thermal imaging was performed using 
the Thermovision A40 supplied by FLIR systems, (User Manual: Publ.No. 1557813Rev.a72-
October 29, 2004). The potential for heat conduction from an activated piezo actuator at high 
frequency (5000 Hz) through the aluminium disc and into the culture media could 
theoretically affect the viability of the MSCs.  
 
An initial or starting time point in which the piezo actuator was inactive was first determined. 
Next one activated piezo actuator (bioreactor) was compared concomitantly to an inactive 
bioreactor at the frequency of 5000 Hz for 5 mins. Subsequently as an extreme condition an 
activated piezo actuator at 5000 Hz and 20 V peak to peak was concurrently compared against 
an inactive actuator with exactly the same set up. All these experiments were performed with 
and without the presence of culture media in the petri dish to determine if heat which could 
potentially be generated would alter the media temperature through convection. (Figure 2.4), 
provides the results of these experiments. 
 
Note as well as performing thermal analysis an investigation into the possibility of shear force 
being a contributing variable in the experimental set up was also investigated by previous 
analysts. This was performed by determining the movement of fine particulate fluorescent 
dyes in an active nanokicking bioreactor, for this work see reference (Nikukar et al., 2013).  
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2.3.7    Quantitative real-time (qRT-) PCR  
2.3.7.1    Pelleting of cells after experimental culture 
• Triplicates of triplicates (initially 45 samples brought down to 15 with triplicates) were 
cultured for a given period of time. The sample populations were as follows: 
• Group A: No exposure to nanokicking 
I) MSCs grown in osteogenic media a 1 cm2 flat polycarbonate substrate-(Positive 
Control). 
II) MSCs grown on a 1 cm2 flat polycarbonate substrate - (Negative Control) 
III) MSCs grown on a 1 cm2 NSq-50 nanotopography polycarbonate substrate 
• Group B: Cells exposed to nanokicking 
       IV) MSCs grown on a 1 cm2 flat polycarbonate substrate 
       V) MSCs gown on a 1 cm2 NSq-50 nanotopography surface 
• For all the samples, the 1 cm2 polycarbonate base was removed and placed into a 10 
cm Petri dish. 
• The 1 cm2 base was inverted so that the top (the surface on which the MSCs were 
grown) was facing down. To this was then added 1 mL trypsin/versene mix (0.5 
mL/20 mL). The 3 triplicates were then placed in the incubator for between 5-10 mins, 
with observation for detachment. After this time, 500 µL DMEM media was then 
placed into each Petri dish to quench the trypsin catalysis reaction. 
• While working in a fume hood, a scraper was then used to thoroughly scrape all the 
cells from each 1 cm2 surface, combining the contents of 3 surfaces into 1.  A syringe 
was then used to carefully take up the 1.5 mL solution containing the suspended cells, 
this volume was placed into a 1.5 mL Eppindorf tube.  
• Each triplicate per sample group was then centrifuged for 5 mins at 14000 rpm. 
• A pellet was observed and the media was removed using a pipette without disturbing 
the pellet, leaving behind the pellet in as little media as possible. 
• The samples were immediately placed on dry ice (CO2) at -100ºC, and then stored 
overnight at -70 ºC. 
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2.3.7.2       RNA extraction   
• When dealing with RNA at the qRT-PCR kit, nitrile gloves were used at all times to 
prevent contamination of the very labile RNA samples. 
• Firstly, the necessary solutions as dictated by the Qiagen qRT-PCR kit were made. 
• Ethanol:H2O / 70%:30% (deionised Millipore water) 
• Ethanol:H2O / 80%:20% (deionised Millipore water) 
• Buffer RLT:  by adding 450 µL B-mecaptoethanol (B-me) to the 45 mL Buffer RLT 
provided by Qiagen. (i.e. 10 µL B-mecaptoethanol per 1 mL Buffer RLT). 
• Buffer RPE (concentrate supplied): 44 mL ethanol (absolute) to 11 mL buffer RPE 
concentrate, to give 55 mL buffer RPE working solution. 
• The samples were taken from the -70ºC storage back onto dry ice and brought to the 
working lab. To each sample from on ice (while still frozen) was added 350 µL Buffer 
RLT to the Eppindorf tube with the pellet. This was then vortexed for 5-10 secs to 
ensure mixing. 
• To each solution was again added 350 µL 70% ethanol solution. It was then agitated 
using the pipette to mix. 
• This solution was then added to a special MinElute spin column, which was placed 
into a 2 mL flow through collection tube (both supplied by Qiagen). 
• The samples were then centrifuged for 60 secs at 10000 rpm. The flow through was 
then discarded. 
• To the MinElute spin column cartridge was then added 350 µL buffer RW1. The 
samples were then centrifuged for 60 secs at 10000 rpm. The flow through was then 
discarded. 
• At this point it is necessary to resuspend the DNase I (provided in powder form by 
Qiagen). To make the DNase I incubation mix 10 µL DNase I stock was added to 70 
µL RDD (supplied by Qiagen) for just one sample. In order to make, for example, 
sufficient quantities for 15 samples, 16 times the amount of the incubation mix was 
prepared. 
For this 550 uL RNase free H2O was added to the DNase I stock, and the solution was 
agitated gently by inverting. No vortexing was used as the DNase I was sensitive to 
physical denaturation. 
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160 µL DNase I stock solution was then added (10 x 16 samples) to 1120 µL Buffer 
RDD solution. The solution was then mixed with gentle inverting to form DNase I 
incubation mix. 70 µL of this mix was then added directly to each sample MinElute 
spin column membrane. 
• The samples were then left to incubate for 15 minutes at ambient temp (20-35ºC). 
• Next 350 µL Buffer RW1 was added to the RNeasy MiniElute spin column cartridge. 
The lid was closed and the tube centrifuged for 60 secs for at 10000 rpm. This was 
used to wash the spin membrane. Both the flow through and collection tube were then 
discarded. 
• The MinElute cartridge was then placed into a new 2 mL collection tube (supplied by 
Qiagen). To the cartridge was added 500 µL Buffer RPE to the spin column. The lid 
was closed and the tubes centrifuged for 60 Secs at 10000 rpm. This washed the spin 
column membrane and the flow through was discarded. 
• Then 500 µL 80% ethanol was added to the MinElute spin column cartridge. The lid 
was closed and the tubes centrifuged for 2 mins at 10000 rpm. Both the flow through 
and collection tube were then discarded. 
• The cartridge was then placed into a new 2 mL collection tube. The lid of the spin 
column cartridges were then opened, and centrifuged at 14000 rpm for 5 mins. Both 
the flow through and collection tubes were then discarded. This step was used to dry 
the spin column membrane, since residual ethanol would interfere with downstream 
reactions. Centrifuging with the lids opened ensured that no ethanol was carried over 
during RNA elution. 
• The MinElute cartridge was placed into a new 1.5 mL collection tube. To this was 
then added 14 µL RNA free water. This was carefully added directly to the centre of 
the column cartridge membrane. The lid was closed and the Eppindorf tube was 
centrifuged at 14000 rpm for 2 mins, in order to elute the RNA. The dead volume of 
the RNeasy MinElute column was 2 µL, hence 14 µL only yield a 12 µL volume of 
RNA.  
• At this point if necessary the RNA was frozen at – 70ºC, or directly tested on the 
Nanodrop system for quantification of the RNA content (concentration). 
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2.3.7.3        RNA quantification  
• Quantification of the levels of RNA in each sample was performed using a 
spectrophotometer Nanodrop system (UV detection). By the following process. 
• Firstly, a P2 – 2 µL Pipette was used. 
• The nucleic acid setting was chosen on the nanodrop software. 
• The UV analysis mount was cleaned with 2 µL RNA free water, and the system was 
background initialised. 
• ng/µL units of concentration was selected. 
• The top was wiped and 2 µL RNA Free water was placed on the analyser, and a blank 
determination was performed. 
• Each triplicate set of samples was then analysed by adding 1.5 µL of volume directly 
on the analyser pin hole 
• Once a result report was printed all the values of the RNA samples were normalised to 
be at the same level as the lowest sample concentration, by adding different volumes 
RNA free water (supplied by Quiagen).  
• Note, the comparison absorption between the wavelengths of 260/280 nm and 260/230 
nm were used for the quantification of the RNA.  
 
2.3.7.4      Reverse transcription process  
• 12 µL of the normalised dilutions for each sample were added to a 0.2 mL (200 µL) 
reverse transcription PCR – Cup (supplied by Qiagen). 
• To each of the samples was then added 2 µL gDNA wipeout buffer, (provided by 
Qiagen). 
• Following this each sample was run at 42ºC for 2 mins, on the thermal Cycler (PCR) 
Master cycler system. 
• The Stock solution was then made as given in (Table 2.2) below (allowing for 15% 
extra) 
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 1 x Mix 16 x Mix 
Quantiscript reverse transcriptase 1 µL 16 µL 
Quantiscript RT buffer 4 µL 64 µL 
Primer mix 1 µL 16 µL 
    
Table 2.2: qRT-PCR Reverse transcription solution volumes 
• 6 µL of the Stock Solution was then added to each well, to give a total volume of 20 
µL. 
• The second program was then run to reverse transcribe the RNA into cDNA. This took 
approximately 20 mins. 
 
Temp Time 
42ºC 15 
93ºC 3 
4ºC Hold 
  
Table 2.3: qRT-PCR reverse transcription thermal program 
 
• Once complete the cDNA, if necessary was stored at 4˚C. 
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2.3.7.5       Analysis of qRT-PCR 
• Where necessary the samples were taken out of storage and to each of the (200 µL 
size) reverse transcription PCR cups was added 30 µL DNA free water (supplied by 
Quiagen), to give a total volume of 50 µL. 
• Master mixes were then prepared, one for the house keeping gene Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH - used as an internal reference standard gene) and 
the other genes being assessed, see (Table 2.5) for a list of the genes determined. 
These were prepared with 10% extra volume. 
 
 1x 16x stock 
Mix 
SYBR Green PCR Kit 33 µL 528 µL 
Forward primer (100 
µM) 
0.33 µL 5.28 µL 
Reverse primer  (100 
µM) 
0.33 µL 5.28 µL 
DNA free water 25.74 
µL 
411.84 µL 
 
Table 2.4: Volumes of primers and PCR kit solutions used for the PCR cycle analysis. 
 
• 59.4 µL of the Master mix was placed into a 1.5 mL Eppindorf tube. To this was then 
added 6.6 µL of cDNA from each of the samples. This was then used to create 3 
triplicates of each sample, as a result there were 9 wells corresponding to each sample. 
• 20 µL of the each was then aliquoted into the correct well on a PCR 64 well plate. 
Once this was done for the GAPDH gene, it was then repeated for the genes being 
assessed placing the samples in a different but known location on the plate. 
• Following this a negative control or Blank was also placed in a known location on the 
64 well plate corresponding to each gene. This comprised of 18 µL of the Master mix 
and 2 µL of DNA free water. 
• The wells were then covered with a specific thin plastic and sealed tightly using a 
scraper. 
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Gene Forward Primer Reverse Primer 
GAPDH TCAAGGCTGAGAACGGGAA TGGGTGGCAGTGATGGCA 
Beta-Actin CCAACCGCGAGAAGATGA CCAGAGGCGTACAGGGATAG 
HPRT1 TGACCTTGATTTATTTTGCATACC CGAGCAAGACGTTCAGTCCT 
TFRC TGGCAGTTCAGAATGATGGA AGGCTGGAACCGGGTATATGA 
GUSB CGCCCTGCCTATCTGTATTC TCCCCACAGGGAGTGTGTAG 
 
 Table 2.5: Primers for genes used to perform qRT-PCR, housekeeping screen experiment, 
the culture time for the housekeeping gene experiment was for 3 days at 10000 Hz. 
Note: 
glyceraldehyde 3-phosphate dehydrogenase  - (GAPDH)  
hypoxanthine phosphoribosyltransferase  - (HPRT1) 
β-glucuronidase - (GUSB)  
transferrin receptor -  (TFRC) 
The 7500 Real Time PCR system was used to perform the amplification and GAPDH served 
as the internal reference standard gene (housekeeping gene) against which the expression of 
the target genes were assessed. For accurate PCR quantification the 2-∆∆Ct method was used to 
determine gene expression and amplification of 3 triplicates from an unstimulated control (the 
negative control sample listed in section 2.3.7.1) was compared against the stimulated sample 
conditions.  
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2.3.8    Statistics 
To determine significance between controls and test samples the probability values have been 
quoted to an accuracy of 95% and 99% (*p < 0.05 and **p < 0.01 respectively), as an 
acceptable way to quote significant data. Kruskal-Wallis ANOVA, for use with 
non-parametric data, was used to compare significance in PCR experiments, using the Prism 
software package. Tukey’s post hoc test was further performed for comparison of significance 
of the control to multiple test samples. 
 
2.3.9  Finite elemental modelling (ANSYS) 
Simulated models of Corning petri dishes, and the bioreactor materials were developed in 
ANSYS finite element software (ANSYS, Canonsburg, PA). Models were developed in 
ANSYS Workbench v14.0 with analysis involving use of the Harmonic Response package to 
provide values for deformation at user defined frequencies.  
The culture plate component was modelled with a polystyrene dish bonded to an alumium 
disc adhered by epoxy. A similar method was used to model the piezo actuator attached to the 
aluminium block and the polycarbonate NSq-50 substrate adhered within the 
polycaprolactone. For this analysis, a vibration frequency of 1000 Hz with 28 nm amplitude 
was applied to the models to compare amplitude consistency. Throughout all the analysis, 
mesh relevance was set at 0 giving a medium mesh density. 
Harmonic response analysis was used to study the frequency dependant effects of deformation 
of the construct taking into account all the different materials. Vibration condition was set in 
the range of 500 to 10000 Hz at 20 nm to encompass the experimental value of 1000 Hz. 
Harmonic response analysis is strictly linear so accuracy would be limited to the linear range 
of the material. Meshing size was set to coarse to reduce computational time. The additional 
impact of gravity was incorporated through an inertial acceleration of 9.81 ms-1. Note the 
ANSYS modelling was performed by Mr. Peter Childs, as stipulated in the 
acknowledgements. 
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2.4  Results 
2.4.1  Thermal analysis of the piezo actuator 
The thermal analysis carried out showed that the ceramic material which was used to build the 
piezo actuator by PI was in fact an excellent insulator, and that the piezo actuator could be 
vibrated at high frequencies without generating a noticeable heat increase between activated 
and inactive bioreactor set ups. What’s more even at the extreme condition of 5000 Hz and 20 
V peak to peak amplitude, which would also be used to test the onset of osteogenesis; no 
noticeable increase in heat was observed. It is worth noting that the experiment was only 
determined for a maximum of 10 mins although culturing could be carried out for weeks. The 
rationale here; after discussion with expert physicists was that if after 5-10 mins of activation 
no heat was detected, it could be accepted that this would be status quo through the duration 
of culture. Observe (Figure 2.4) for a summary of the thermal imaging results determined.   
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Figure 2.4: Temperature profile data, infrared images with experiments performed at room 
temperature. Piezo actuator on the left hand side is inactive and piezo actuator on right hand 
side is activated in diagrams (B), (C), and (E) : -  (A) initial time point with no media in the 
Petri dishes, no piezo activation. (B) 5 mins of the piezo actuator activation at 5000 Hz and 20 
V with no media in Petri dishes. (C) 10 mins of the piezo actuator activation at 5000 Hz and 
20 V with no media in petri dish. (D) Initial time point with hepes media in petri dishes. (E) 5 
mins of the piezo actuator activation at 20 V with hepes media in Petri dish. No thermal 
change was observed for any of the activated piezo devices relative to the inactivated devices, 
with or without media present in the Petri dish. This data provides thermal stability for the 
piezo actuator set up. All these samples were analysed in the bench. Figure used with 
permission from the publisher (Pemberton et al., 2015). 
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2.4.2    Piezo bioreactor mechanical integrity characterisation 
Using ANSYS finite element modelling software, the vibration apparatus (aluminium, Petri 
dish and NSq-50) was modelled to determine the lowest resonant frequencies and potential 
physical deformations at 1000, 3000, 5000 and 10000 Hz. Resonances or deformations even 
at the nanometre level can alter the accelerative forces experienced by individual cells, and 
hence limit the reproducibility and control of the experiments. The modelled deformations, 
shown in (Figure 2.5 D), indicate that the level of vibration control is diminished at 10000 Hz 
with even the polycarbonate substrate being expected to start physically deforming.  The 
model shows that at 10000 Hz, two corners of the substrate move with amplitudes of 50 nm 
whilst the other two exhibited reduced amplitudes below 10 nm, which are also moving out of 
phase with the rest of the surface, see (Figure 2.7) for this data. This was supported by 
interferometric measurement which showed some corners moving at 18 nm whilst others 
moved at 76 nm giving large standard deviations (see Figure 2.6 A). Deformation was also 
predicted at 5000 Hz in the corners of the polycarbonate substrates. Interferometry confirmed 
this with increased amplitudes up to 65 nm at the edges as opposed to 16 nm at the centre see 
(Figure 2.7). The data however showed 1000 and 3000 Hz to be stable reproducible 
frequencies for use with this bioreactor set up. Peak acceleration can be calculated using the 
average amplitudes measured by interferometry and is given by A0ω
2 where A0 is the 
amplitude and ω is the angular frequency. For 1000, 3000, 5000, and 10000 Hz this equates to 
peak accelerations of 0.1g, 1g, 1.6g and 14g respectively (6.5 g at the corners, 5000 Hz and 20 
g at the corners, 10000 Hz). As per the interferometry characterisation in (Figure 2.6 A), the 
nanometre level displacements measured at 20 V at the working frequencies used were as 
follows: 1000 Hz – 30 nm, 3000 Hz – 28 nm, and 5000 Hz – 16 nm.  
The addition of multiple piezo actuators wired in parallel to the same signal generator power 
source was observed to have a negligible change on the height of the nanoscale displacements 
observed see (Figure 2.6 B), and the results remained in line with the specification provided 
for the piezo actuator by PI. 
Note the work for the ANSYS finite element modeling and interferometry measurements 
were performed in collaboration with Mr. Peter Childs, a physics PhD student from the 
University of West of Scotland. 
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Figure 2.5: Characterisation of the 2D bioreactor: ANSYS harmonic response simulations of 
the vibration setup at (A) 1000 Hz, (B) 3000 Hz, (C) 5000 Hz and (D) 10000 Hz. Increasing 
deformation of the NSq-50 is seen as the frequency increases. Petri motion and piezo motion 
are out of phase at 5000 Hz due to resonant frequencies occurring lower than this (resonance 
causes an increase in magnitude of the displacement, which may cause poor reproducibility in 
future experiments). Figure used with permission from the publisher (Pemberton et al., 2015) 
. 
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Figure 2.6: Empirical nanokicking displacement Assessment: (A) Graph showing the use of 
interferometry to determine displacement (nm) relative to peak to peak potential difference 
(V) of the piezo actuator. Determinations performed at varying frequencies from 500 Hz to 
10000 Hz, N= 4 material replicates (average of 4 Petri dishes and piezo actuators, with each 
measurement being the average of 5 interferometry readings), a resonance at ~ 3000 Hz 
means that 3000 Hz has a higher displacement than 5000 Hz. (B) Determination of the effect 
of increasing the number of piezo actuators connected in parallel on the displacement (nm) of 
the piezo actuators at 20 V for 1000 Hz and 5000 Hz. The change was found to be negligible 
and within the specification of the piezo actuator apparatus. Figure used with permission from 
the publisher (Pemberton et al., 2015). 
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Figure 2.7: Interferometric measurement showing the standard deviation and range of 
amplitude displacement of the polycarbonate substrate motion comparing the corners and 
centres at the frequencies of 1000 Hz, 3000 Hz, 5000 Hz and 10000 Hz. The data shows that 
10000 Hz has the most extreme level of variation in displacement, and is the most extreme 
frequency. Figure used with permission from the publisher (Pemberton et al., 2015). 
. 
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2.4.3    Biological integrity of piezo vibration 
Due to the fact that this research was novel and had not been attempted previously, it was 
important to confirm the selection of the correct housekeeping gene to be used as a biological 
internal reference standard for qRT-PCR analysis. Before commencing transcriptional 
analysis of high frequency nanokikced samples a qRT-PCR scouting experiment ensued. This 
entailed the piezo stimulation of fibroblast cells for 3 days at the extreme vibrational 
condition of 10000 Hz and 20 V peak to peak (equating to accelerations between 3.6 g and 20 
g). The expressions of 5 well known qRT-PCR housekeeping genes were assessed against 
their unstimulated controls. As researched from the literature the genes chosen for the 
scouting experiment were β-actin, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), 
hypoxanthine-guanine phosphoribosyltransferase (HPRT1), β-glucuronidase (GUSB) and the 
transferrin receptor (TFRC) (Bas et al., 2004; Bhoopathi et al., 2011; Iwaki et al., 2003; 
Rosales-Reyes et al., 2012; Thellin et al., 1999). Out of these, GAPDH was found to be the 
most stable gene with the lowest cycle threshold, as a result this was chosen as the internal 
reference housekeeping gene for all nanokicking stimulated qRT-PCR experiments 
throughout this PhD, see (Figure 2.8) for results. 
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Figure 2.8: qRT-PCR housekeeping gene (internal genomic reference standard) scouting 
experiment: Fibroblast cells were nanokicked at extreme conditions for 3 days, following this 
the PCR cycle thresholds for specific housekeeping genes were compared against 
unstimulated controls. (A) GAPDH was found to be the most stable housekeeping gene with 
the lowest cycle threshold, other genes assessed included (B-Actin, HPRT1, GUSB and 
TFRC). (B) GAPDH was then used as a house keeping gene for comparison of all other 
genes. All experiments were carried out at 10000 Hz at an amplitude of 20 V peak to peak.  
N=5 (one experiment with 5 material replicates). Figure used with permission from the 
publisher (Pemberton et al., 2015). 
 
2.5     Discussion of results 
The mechanical integrity of the 2D piezo bioreactor which was constructed was found to be 
suitable for use when interrogated for thermal and mechanical stability and reproducibility. 
The design used was importantly not susceptible to shear force either.  In terms of thermal 
consistency, it appeared that Physik Instrumente GmBH as an engineering company had 
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factored this potential issue into their construction of the piezo actuator and used the correct 
insulating materials. The use of heated polycaprolactone as a biocompatible glue was also 
suitable to securely fasten the polycarbonate NSq-50 nanotopographical substrates to the petri 
dish efficiently transferring the piezo nanodisplacement, as was confirmed by the 
interferomeotric measurements.  
The interferometric empirical measurements matched closely with the results predicted by the 
ANSYS finite element modelling software, corroborating the expectation of innate resonances 
around 3000 - 4000 Hz, increased accelerations at 5000 and 10000 Hz and even physical 
deformations at 10000 Hz. The higher acceleration forces were made evident by the large 
standard deviations or differences in nanometre displacements between the centre and corners 
observed in the activated bioreactor.  
By qRT-PCR the fibroblast cells (cells differentiated from MSCs which help to synthesis the 
extracellular matrix) were observed to have biological integrity for all the housekeeping genes 
that were assessed at an extreme condition of 10000 Hz. Even B-actin which comprises the 
microfilaments, which in part composes the cell cytoskeleton showed not to change to a large 
degree after 3 days of vibrational stimulation, when comparing cycle thresholds against 
unstimulated controls. As discussed in the introductory chapter it can also be further argued 
that it is in fact F-actin which is attached to the focal adhesion and it is primarily F and α - 
actin which play more significant roles in cell structure, contractility and movement.  
Further resulting biological changes in the cells may perhaps then take initiative from the 
integrins and focal adhesions as nanokicking stimulation ensues. Out of all of the 
housekeeping genes assessed GAPDH was seen to have the lowest cycle threshold and was 
thought to be most stable, hence this was chosen as the biological internal reference standard 
which would be used for future qRT-PCR analyses to determination the genotype 
(transcriptome) of MSCs which had been stimulated by nanokicking. 
 
2.6   Conclusion 
The design which was engineered for 2D high frequency vibrations of MSCs was found to be 
fit for purpose, when interrogated for thermal, mechanical and biological integrity. This 2D 
bioreactor, see (Figure 2.2), was hence suitable for introducing low amplitude high frequency 
nanometre displacements to a layer of MSCs cultured on an NSq-50 nanotopographical or flat 
surface. 
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3.1  Introduction 
The work performed in chapter II included determining the most suitable housekeeping gene 
for genomic assessment; confirmation and validation of the mechanical integrity of the 2D 
bioreactor and assurance of the bioreactors suitability for biological experiments. Carrying on 
from this, chapter III provides an in depth assessment into the potential of the 2D vibrational 
bioreactor to differentiate multipotent MSCs into osteoblasts. To confirm this capacity, the 
flow of the biological information from genes to proteins to biological product was assessed. 
Finally, experimentation was subsequently performed at the mineralisation level for the 
presence of deposited calcium and phosphate – the constituents of apatite, the mineralised 
component of the bone matrix. It is hypothesised that this bioreactor in effect has the ability to 
provide a direct route to intramembranous ossification (ossification de novo) without the need 
for endochondral ossification or the preliminary formation of cartilage in the first instance. 
 
3.2  Materials and methods 
3.2.1  Materials 
Note: Several of the reagents, protocols and the materials listed in chapter II were also 
prepared in the same fashion for chapter III; as a result these have not been relisted in (Table 
3.1). Only new methods, protocols and reagents distinctive to chapter III have been listed in 
(Table 3.1) and explained throughout section 3.2. Refer back to the original list of reagents 
from chapter II. 
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Materials and Reagents Source / Supplier/ prepared 
Osteocalcin mouse monoclonal IgG antibody Santa Cruz Biotechnology, ABOC-5201, Lot: 
G3014  
Osteopontin mouse monoclonal IgG antibody Santa Cruz Biotechnology, AKM2A1 Lot:G1613 -  
GAPDH rabbit monoclonal antibody  Abcam, ab128915, LotGR179384-1 
anti-mouse IRDye 680 CW LI-COR 926-68077 
anti-rabbit IRDye 800 CW LI-COR 926-32213  
DAPI(4,6-diamidino-2-phenylindole) Vector Laboratories H-1200 
Phalloidin conjugated - FITC (Fluorescein)   Invitrogen R415 
Streptavadin conjugated - rhodamine Vector Laboratories SA-5001 
Raman spectrometer Renishaw InVia 
Fluorescent and light microscope Zeiss Axiophot BMBA011033 
Silver nitrate Sigma Aldrich 85228-50G 
Sodium thiosulphate BDH Analar 102684G 
Aluminium sulphate VWR Chemicals 12362.A1 
Alizarin Red  (ARS) Sigma-aldrich A5533-25G 
Ammonium hydroxide (5 M) Centre for Cell Engineering, University of Glasgow 
Bovine serum albumin (FBS) Fisher Scientific – BP9700-100 Lot: 61-1247 
Milk protein blocker Marvel R.No.92962 
Nuclear fast red 229113 Aldrich (CAS Number 6409-77-4) 
1 x PBS Centre for Cell Engineering, University of Glasgow 
PBS/Tween 0.5% Centre for Cell Engineering, University of Glasgow 
Perm Buffer Centre for Cell Engineering, University of Glasgow 
Fixative Centre for Cell Engineering, University of Glasgow 
PBS/Tween 0.1% Centre for Cell Engineering, University of Glasgow 
 
Table 3.1: List of materials and reagents used in chapter III 
 
3.2.2  Cell culture and media preparation 
See section 2.3.4, for the methodology which was used to culture and feed the cells during the 
duration of the nanokicking stimulation and OSM stimulation. Although the cell culture 
preparation was the same, the durations which the experiments were carried out for were 
differed depending on whether transcription, protein or mineralisation was being assessed.  
Chapter III – Osteogenesis using the 2D bioreactor – nanotopography & nanokicking  
62 
 
3.2.3  Quantitative real-time (qRT-) PCR 
See section 2.3.7 of chapter II, for the methodology and preparation steps used to harvest the 
cells after experimental culture and isolation to quantify the RNA and perform quantitative 
polymer chain reaction analysis. (Table 3.2) below lists the specific gene primers which were 
used to perform the quantification experiments. GAPDH served as the house keeping gene or 
internal genetic reference standard for the transcription (mRNA) quantification. 
Gene Forward Primer Reverse Primer 
GAPDH TCAAGGCTGAGAACGGGAA TGGGTGGCAGTGATGGCA 
BMP2 CCCACTTGGAGGAGAAACAA AGCCACATTCCAGTCATTCC 
RUNX2 GGTCAGATGCAGGCGGCCC TACGTGTGGTAGCGCGTGGC 
Osterix GGCAAAGCAGGCACAAAGAAG AATGAGTGGGAAAAGGGAGGG 
Osteonectin 
(ONN) 
AGAATGAGAAGCGCCTGGAG CTGCCAGTGTACAGGGAAGA 
Osteopontin 
(OPN) 
AGCTGGATGACCAGAGTGCT TGAAATTCATGGCTGTGGAA 
Osteocalcin 
(OCN) 
CAGCGAGGTAGTGAAGAGACC TCTGGAGTTTATTTGGGAGCAG 
 
 Table 3.2: Primer sequences for genes used to perform qRT-PCR 
3.2.4  In cell western 
3.2.4.1     Preparation of in cell western reagents 
Preparation of fixative 
10 mL (38%) formaldehyde was placed into 90 mL PBS along with 2 g sucrose. The solution 
was then left at 37ºC for 15 minutes to dissolve the sucrose. 
Preparation of perm buffer 
The following compounds were added together: 10.3g sucrose, 0.292g NaCL, 0.06g MgCL2 
(hexahydrate), 0.476g Hepes in 100 mL PBS. The solution was then adjusted to pH 7.2 using 
NaOH. 0.5 mL Triton X-100 was then added. 
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Preparation of blocking buffer 
To 50 ml x 1 PBS was added 0.5 g milk protein (i.e. 1%), this was stirred for 5 minutes or 
alternatively the blocking buffer was heated to 37 º C to fully dissolve the milk powder. 
Preparation of primary antibody 
• Osteocalcin or Osteopontin mouse: 20 µL primary antibody was added to 1 mL of 
the blocking buffer prepared above, (1:50 dilution). 
• GAPDH rabbit: 2 µL primary antibody GAPDH was added to 10 mL of the blocking 
buffer prepared above (1:5000 dilution) 
• Note: these two were combined to make one primary antibody solution. 
Preparation of secondary antibody 
• Osteocalcin or Osteopontin (donkey anti-mouse) 680 nm wavelength - 1 µL 
secondary antibody was added into 10 mL of the blocking buffer prepared above, 
(1:10000 dilution). Note 0.2% Tween® 20 was added to the blocking buffer used as 
diluents for the secondary antibody. This was 20 µl Tween in 10 ml blocking buffer, 
which helped to lower the background fluorescence. 
• GAPDH (donkey anti-rabbit) 800 nm wavelength - 1 µL secondary antibody was 
added into 10 mL of the blocking buffer prepared above, (1:10000 dilution). Note 
0.2% Tween® 20 was added to the blocking buffer used as diluents for the secondary 
antibody. This was 20 ul Tween® 20  in 10 ml blocking buffer. 
• Note: these two were combined to make one secondary antibody solution. 
Preparation of wash buffer  
To 1000 mL x 1 PBS was added 1 mL Tween® 20 (i.e. 0.1% Tween® 20). 
 
3.2.4.2  In cell western procedure 
• Fixative was used to fix the cells for 15 minutes at 37ºC. 
• The cells were then permealised in perm buffer at 4ºC for 4 minutes. 
• The perm buffer was then removed. 
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• The blocking buffer (PBS /1% milk protein) was added. The blocking procedure was 
performed for 1.5 hours at room temperature with moderate shaking on a plate shaker. 
• The blocking solution was then removed. 
• The primary antibody was then added and incubated at 37ºC in a warm room for 2 
hours.  
• The primary antibody was removed and the sample washed 5 separate times with wash 
buffer for 5 minutes each at room temperature with gentle shaking. Enough buffer was 
used to completely submerge the sample. 
• The wash buffer was removed and the sample was washed once in blocking buffer. 
• The secondary antibody was then added and left for 1 hour in a shaker, covered in tin 
foil. 
• The secondary antibody was removed and the plate was washed 5 times with wash 
buffer, for 5 minutes for each wash. This included gentle shaking while covered in 
foil. The last wash was carried out solely in PBS so as to remove any bubbles caused 
by the surfactant Tween® 20. 
• The 2 cm2 polycarbonate substrates were then removed and lightly dried with white 
paper, turned upside down and moved to a newly labelled Corning 6 well plate. 
3.2.5  Immunofluorescence  
3.2.5.1  Preparation of the immunofluorescence reagents 
Preparation of fixative 
10 mL (38%) formaldehyde was placed into 90 mL PBS along with 2 g sucrose. The solution 
was then left at 37ºC for 15 minutes to dissolve the sucrose. 
Preparation of perm buffer 
The following compounds were added together: 10.3g sucrose, 0.292g NaCL, 0.06g MgCL2 
(hexahydrate), 0.476g Hepes in 100 mL PBS. The solution was then adjusted to pH 7.2 using 
NaOH. 0.5 mL Triton X - 100 was then added. 
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Preparation of PBS/ 1%BSA 
To 100 mL 1 x PBS was added 1 g bovine serum albumin (BSA). The solution was mixed to 
thoroughly dissolve the BSA in solution. The volume of solution prepared was scaled up or 
down depending on what was required. The solution was stored in the freezer when not in 
use. 
Preparation of wash buffer 
0.5 mL Tween 20 was added to 100 mL 1 x PBS (PBS/Tween 0.5%). 
Preparation of primary antibody 
3 uL phalloidin (to stain actin microfilaments) was added to 1 mL PBS/BSA solution (dilution 
1 to 333). To the same volume was added 20 uL either osteopontin or osteopontin (rabbit) 
primary antibody, depending on which was being assessed per sample (dilution 1 to 50). 
Preparation of secondary antibody 
40 uL biotinylated anti-rabbit was added to 2 mL PBS/BSA (dilution 1 to 50). 
Preparation of tertiary complex 
40 uL streptavidin (conjugated rhodamine/texas red) was added to 2 mL PBS/BSA (dilution 1 
to 50). 
3.2.5.2  Immunofluorescence procedure 
• The cells were first rinsed with 1 x PBS wash buffer. 
• 38% formaldehyde solution was used to fix the MSCs directly onto the polycarbonate 
NSq-50 or flat substrate, at 4˚C for 5 minutes. 
• Permeablisation buffer was used to permealise the cells, the substrates were incubated 
at 37˚C for 5 minutes.  
• PBS/1%BSA was used as a blocking agent and the substrates were first incubated in 
the blocking buffer for 5 minutes at 37˚C. The solution was removed and the primary 
antibody was added, the samples were wrapped in foil and incubated at 37˚C for 1.5 
hrs.  
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• The primary antibody was removed and the samples were washed for 3 x 5 minutes 
using the wash buffer. The final wash was performed with agitation on a shaker. 
• The secondary antibody was then added and the samples were wrapped in foil and 
incubated at 37˚C for 1 hour. 
• The secondary antibody was removed and the samples were once again washed for 3 x 
5 minutes using wash buffer, with the last wash being performed with agitation.  
• The wash buffer was removed and tertiary complex was added. The samples were 
once again wrapped in foil and incubated at 4˚C for 30 minutes. 
• The tertiary complex was removed and the same wash procedure was once again 
undergone. 
• Following on from this, a small drop of vectroshield-DAPI (to stain the nucleus) was 
added to the sample and they were subsequently inverted and fixed to a microscope 
coverslip. The samples were sealed using nitrocellulose/ butyl acetate (nail varnish). 
• Microscopy was performed using an Axiophot-Zeiss Germany and where necessary 
the samples were stored at 4˚C.  
 
3.2.6  Raman spectroscopy  
• MSCs were cultured on either polycarbonate flat or NSq-50 substrates and exposed to 
piezo stimulation for the duration of 27 days.  
• The substrates were removed and quickly dipped into deionised water to remove any 
excess basal media. The substrates were then directly introduced to the Raman system 
for assessment.  
• Firstly, a sample of bovine cortical (compact) bone was scanned using the Raman 
spectrometer, to serve as a reference for perfectly mineralised bone. 
• Subsequently, it was determined that 960 cm-1 was the dominant scattering 
wavenumber in the distinctive fingerprint region for bovine cortical bone, and hence 
all test samples were scanned at this wavenumber to determine the presence of 
phosphate. 
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• Visible spectroscopic scans were measured using a Renishaw InVia Raman 
spectrometer equipped with a 785 nm line-focus laser.  
• A 0.25 cm2 region of each substrate sample was assessed with a single static scan 
measurement with spectral acquisition at 960 cm-1.  
• A Leica microscope was used to observe the test samples at magnification x 20.  
• No sample preparation was required before assessment by Raman spectroscopy. 
 
3.2.7  Alizarin Red S staining 
• Alizarin red solution was prepared at a concentration of 40 mM by adding 1.369 g 
Alizarin red powder to 100 mL of distilled water. The pH was then altered to 4.2 from 
3.5 using NH4OH.  
• The solution was then filtered through a 0.2 µM filter. 
• Following on from this MSCs which were cultured in basal media for 34 days exposed 
to vibrational stimulation were fixed using 38% formaldehyde at 37ºC for 15 minutes.  
• The substrates were then covered with 1 ml Alazarin red S and placed on an orbital 
shaker for 1 hour at ambient temperature.  
• The substrates were removed and rinsed 5× with deionised water. An extended rinse 
was then performed on an orbital shaker for 10 minutes.  
• The substrates were allowed to dry and observed using an Axiophot-Zeiss (Germany0 
microscope under white light. 
 
3.2.8  Von Kossa staining 
3.2.8.1 Preparation of Von Kossa reagents 
• 5% silver nitrate was prepared by adding 5 g silver nitrate to 100 mL deionised water. 
The mixture was stirred to form a solution, which could be stored in the dark for up to 
7 days. 
• 5% sodium thiosulphate was prepared by adding 5 g of sodium thiosulphate to 100 mL 
deionised water. The mixture was once again thoroughly stirred. The solution could be 
stored for up to 6 months in the dark. 
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• Nuclear fast red counterstain was prepared at a concentration of 0.1% by adding 0.1 g 
nuclear fast red to 100 mL deionised water. To this solution was also added 5 g 
aluminium sulphate. The solution was boiled while stirring for approximately 10 
minutes until a deep red colour change was observed. This solution was stable for up 
to 2 months. 
 
3.2.8.2 Von Kossa staining procedure 
• MSCs were cultured in basal media for 34 days exposed to piezo stimulation and were 
then fixed using 38% formaldehyde at 37ºC for 15 minutes.  
• 5 % silver nitrate was used to immerse the substrates 
• The substrates were then exposed to UV light for 20 minutes and rinsed in deionised 
water.  
• Following this, 5% sodium thiosulphate was added to the substrates for 10 minutes 
and rinsed with tepid water for 5 minutes followed by deionised water.  
• The substrates were then counterstained with nuclear fast red for 5 minutes and first 
rinsed 3× with deionised water followed by 70% ethanol.  
• Nuclear fast red counterstained the cell nuclei in order to observe the position of the 
active osteoblast cells relative to the calcium phosphate nodules being deposited.  
• The substrates were allowed to dry and were observed using an Axiophot-Zeiss 
(Germany) microscope under white light. 
 
3.2.9  Statistics 
To determine significance between controls and test samples the probability values have been 
quoted to an accuracy of 95% and 99% (*p < 0.05 and **p < 0.01 respectively), as an 
acceptable way to quote significant data. Kruskal-Wallis ANOVA, for use with 
non-parametric data, was used to compare significance in PCR experiments, using the Prism 
software package.  
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3.3  Results 
3.3.1  Transcript analysis of nanokicking induced osteogenesis  
In order to gain an understanding of the genetic changes which would be brought about 
through exposure to high frequency vibrational stimulation, transcriptional analysis of MSCs 
after nanokicking, with and without the added stimulation of the NSq-50 nanotopographical 
surface, was investigated. qRT-PCR was utilised as the technique of choice to assess various 
genes linked to osteogenesis. In particular the genes which were assessed were osteopontin 
(OPN), osteocalcin (OCN), osteonectin (ONN), BMP2, RUNX2 and osterix.  
 
From the preliminary experiments performed, previous work has indicated that 500 Hz was a 
threshold frequency and was insufficient to bring about osteogenesis see (Figure 3.1). Further 
to this, however, the samples which were cultured in osteogenic media, referred to as the 
positive control, did show an increased expression for some key specific osteogenic genes 
over both the 7 and 15 days time points (Figure 3.2).  
Chapter III – Osteogenesis using the 2D bioreactor – nanotopography & nanokicking  
70 
 
 
Figure 3.1: qRT-PCR: Nanokicking at 500 Hz after 4, 7 and 15 days time point on a flat 
polycarbonate surface. The data suggests that osteogenesis did not occur at a frequency of 500 
Hz while there is some initial indication of gene induction, this fades at later timepoints.  All 
experiments were carried out at an  amplitude of 20 V peak to peak. N=3 (one experiment 
with three material replicates), results are mean ± standard deviation *p < 0.05 and **p < 0.01 
by ANOVA. Figure used with permission from the publisher (Pemberton et al., 2015). 
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Figure 3.2: qRT-PCR showing osteogenic media, positive control samples showing an 
up-regulation in key osteogenic genes. N=3 (one experiment with three material replicates), 
results are mean ± standard deviation *p < 0.05 by ANOVA. Figure used with permission 
from the publisher (Pemberton et al., 2015) . 
It was also important to this research to understand if there was a relationship between 
changes in frequency and the nanotopographical surface. To that end, further investigation of 
more osteogenic genes after 7 days of culture, exposed to increasing frequencies with and 
without NSq-50 nanotopography were assessed. This revealed that 1000, 3000 and 5000 Hz 
frequencies all had osteoinductive transcript effects. ONN was observed to be the most 
consistently up-regulated gene (Figure 3.3). It was also observed that nanokicking at 5000 Hz 
further increased expression of osterix, OPN and OCN. The data suggested that nanokicking 
in its own right is very osteogenic, however coupling nanokicking together with the 
osteoinductive NSq-50 nanotopographical surface appeared to have a reductive or cancelling 
effect at the transcript level for the 7 days time point. This for the most part, appeared to be 
the result for all the genes assessed, and 5000 Hz in the absence of the nanotopographical 
surface appeared to provide the optimum osteogenic genetic increase. However, this 
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frequency is unreliable as it appears to be at the threshold of mechanical integrity of the 
bioreactor and hence would be inconsistent, as exhibited by the research performed in chapter 
II.  
 
 
Figure 3.3: qRT-PCR for osteospecific gene expression: Nanokicking stimulation for 7 days 
comparing MSCs nanokicked on an NSq-50 surface against MSCs nanokicked on a flat 
surface. Samples were assessed at 1000 Hz, 3000 Hz and 5000 Hz (1, 3 and 5 kHz) for genes 
(A) osterix, (B) RUNX2 (C) osteocalcin (D) osteopontin (E) BMP2 and (F) osteonectin. 
NSq-50 with nanokicking had an overall reductive effect on these osteogenic genes while 
piezo stimulation on flat surfaces potentiated osteogenesis at the transcriptional level. 
Increasing frequency had an overall augmentative effect on osteogenic genes. All experiments 
were carried out at an amplitude of 20 V peak to peak.  N=3, results are mean ± standard 
deviation *p < 0.05 and **p < 0.01 by ANOVA, the control are at a level of one. Figure used 
with permission from the publisher (Pemberton et al., 2015) . 
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3.3.2  Protein analysis of nanokicking induced osteogenesis 
MSCs were nanokicked for 21 days and were assessed using quantitative in-cell western 
analysis by immunostaining for the proteins OPN and OCN. The protein GAPDH was once 
again used as an internal reference standard to quantitatively compare the expression of OPN 
and OCN as was the case for the qRT-PCR experiments. To remain in line with the genomic 
experiments, nanokicking was carried out both on a flat surface and also on an NSq-50 
surface at 1000 Hz. MSCs were also cultured in OSM for the duration of 21 days and this 
served as a positive control. It was observed that at the protein level assessment, after 21 days 
of culture: the nanokicking; OSM induced differentiation and NSq-50 samples coupled with 
nanokicking all had a positive osteogenic effect.  
 
Furthermore, it was noted that a combination of topography and nanokicking did not have the 
reductive effect which was observed at the earlier genetic level; but rather the highest 
expression of osteogenic proteins were noted at 1000 Hz of nanokicking coupled with the 
NSq-50 nanotopography.  
 
The 1000, 3000 and 5000 Hz stimulation were all seen to be osteogenic at the protein level 
with nanokicking only, with the 3000 Hz providing the best expression of the three (Figure 
3.4A). Fluorescent microscopy of OCN and OPN revealed a similar trend see (Figure 3.4B).  
 
Interestingly, it was observed that whenever nanokicking was used; OCN appeared to be 
highly expressed, and in the osteogenic samples where nanokicking was not used (i.e. NSq-50 
and OSM samples) OPN was observed to be the dominant protein expressed. 
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Figure: 3.4A - In cell western Assay quantitative proteomic analysis for OPN and OCN at the 
21 day time point: OSM was the positive control. MSCs were cultured on an NSq-50 surface 
along with nanokicking at 1000 Hz. Samples were also nanokicked at 1000 Hz, 3000 Hz and 
5000 Hz on a flat surface only. All stimulation was performed at 20 V and samples were 
compared relative to an unstimulated control, N = 2. 3.4B - Immunostaining, qualitative 
analysis for OPN and OCN at the 21 days time point, images chosen are representative of the 
entire sample population, low seeding density areas were chosen to ensure direct NSq-50 
nanotopographical contact by the cells: (A) OSM, positive control, (B) Negative control - 
MSC cultured on a flat polycarbonate surface without nanokicking, (C) NSq-50 
polycarbonate surface only, (D) NSq-50 with nanokicking at 1000 Hz, (E) 1000 Hz 
nanokicking only, (F) 3000 Hz nanokicking only, (G) 5000 Hz nanokicking only. 
Nanokicking at all frequencies was at 20 V. Mag 20×, scale bar =100 µm. Fixed cells were 
stained for OCN & OPN, N = 2. Figure used with permission from the publisher (Pemberton 
et al., 2015). 
Chapter III – Osteogenesis using the 2D bioreactor – nanotopography & nanokicking  
75 
 
3.3.3 Bone matrix mineral deposition analysis of nanokicking 
induced osteogenesis  
Following the flow of biological information from gene to protein; assessment of mineral 
deposition (osteogenesis) through nanokicking after 24 days of culture was determined. For 
this the presence of calcium phosphate deposition was investigated. Apatite deposition would 
only occur in the presence of active osteoblastic cells and this was assessed by three different 
techniques; i.e. Raman spectroscopy, Alizarin red stain (for calcium) and Von Kossa stain (for 
phosphate). The Alizarin red and Von Kossa results on controls (flat and NSq-50 piezo 
unstimulated) gave as expected results with little mineralisation noted on planar controls and 
mineralised nodules observed on NSq-50 see (Figure 3.5A-D). Further to this, strong nodule 
formation was observed with higher piezo frequencies. In line with the protein-level data, the 
mineralization data confirms that the most distinctive nodules were formed at 1000 Hz piezo 
stimulation in tandem with the NSq-50 nanotopography (Figure 3.5 G-H). The results also 
showed that nanokicking at 5000 Hz with and without the NSq-50 nanotopography see 
(Figure 3.5 I-L) also gave mineral deposition albeit to a less extent than what was observed at 
1000 Hz. 
 
Raman spectroscopic assessment was performed after 27 days of nanokicking by determining 
the unique scattering pattern of the fingerprint region of bovine cortical bone, i.e. perfectly 
mineralised bone. It was found that the predominant Raman peak for bone, (which is mainly 
comprised of hydroxyapatite Ca10(PO4)6(OH)2) had a wavenumber of 960 cm
-1. This data is 
provided in (Figure 3.6D). By performing static scans at 960 cm-1 on test samples and 
controls (Figure 3.6 A-C) it was possible to use Raman to determine that 1000 Hz 
nanokicking even in the absence of the NSq-50 surface, was an ideal frequency for mineral 
deposition giving rise to large Ca10(PO4)6 nodules; 5000 Hz also showed some mineral 
deposition but nodules were smaller and less distinctive. It was noted that the Raman results 
were corroborative with Alizarin red and Von Kossa, which gave further credence to the 
deposition of Ca10(PO4)6 apatite through nanokicking. 
These results together suggest that although nanokicking at 1000 Hz appears to provide the 
predominant osteoblastogenic effect, the combination with the NSq-50 surface may be 
optimum for osteoblast differentiation, growth and mineral deposition on a 2D geometry. 
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Figure 3.5:  Bone mineral deposition assessment after 34 days: (A-B) MSCs grown on a 
blank polycarbonate surface only (negative control) showing no presence of Ca10(PO4)6 
nodules. (C-D) MSCs grown on an NSq-50 osteogenic surface showing an increased 
expression of mineralised nodules.  (E-F) MSCs exposed to nanokicking at 1000 Hz on a 
blank polycarbonate surface, showing nodule formation. (G-H) 1000 Hz nanokicking on the 
NSq-50 surface showing the most distinct mineral nodule formation. (I-J) 5000 Hz 
nanokicking on a flat surface showing smaller nodules being formed. (K-L) MSCs exposed to 
nanokicking at 5000Hz on the NSq-50 surface showing evidence of nodule formation. For 
Von Kossa and Alizarin red stains Mag 10×, scale bar = 100 µm, N=2, same scale used for 
each picture. Figure used with permission from the publisher (Pemberton et al., 2015). 
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Figure 3.6: Raman visible spectroscopic scans for Ca10(PO4)6 apatite mineral deposition after 27 days 
of nanokicking. Raman static single scan measurements with spectral acquisition at 960 cm-1 were 
taken for (A-C): (A) Scan of a blank polycarbonate surface (negative control). (B) Scan of a 1000 Hz 
nanokicking sample on a polycarbonate flat surface (C) Scan of 5000 Hz stimulated sample on an 
NSq-50 surface. Red areas show intense Raman scattering at 960 cm-1 indicating the presence of 
Ca10(PO4)2 apatite. (D) the blue line shows the Raman scattering fingerprint region for bovine cortical  
bone with the predominant peak at 960 cm-1, the red line shows the Raman scattering fingerprint 
region for the polycarbonate substrate with the predominant peak at 820 cm-1, no over lapping of 
dominant peaks was observed. Due to the fact that the predominant fingerprint peak for Ca10(PO4)6 
was observed at 960 cm-1 the scans in (A), (B) and (C) were all performed at 960cm-1to confirm the 
presence of calcium phosphate deposition. Note no spectra are shown due to the use of a static scan as 
described in the results. Figure used with permission from the publisher (Pemberton et al., 
2015). 
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3.4  Discussion of results 
The weight of gravity and constant motion while walking and running introduces mechanical 
stimulation at low frequency to the human skeletal system, which may be important in 
maintaining calcification of bone (Ahn and Grodzinsky, 2009). Conversely, astronauts 
exposed to a microgravity environment quickly find that their bones begin to atrophy and 
decalcify (Holick, 1998; Miyamoto et al., 1998). These low frequency vibrations naturally 
introduced to the ligaments, tendons and joints while running and the weight of the 
gravitational pull from the earth support the hypothesis that mechanical stimulation and 
weight bearing (Wolff’s Law) may augment osteoblastogenesis (Chen et al., 2010; Stein and 
D'Ambrosia, 2008). This, in part, provided insight into a rationale to interrogate the potential 
of osteoblastogenesis using nanokicking vibrations. The experimental design, which has been 
discussed in chapter II and used here in chapter III, allows for both high frequency forces and 
weight to be introduced to a population of MSCs as the piezo actuator first expands or 
accelerates upwards and then contracts downwards (Curtis et al., 2013a).  
When considering high-frequency, it is perhaps noteworthy that while bone is thought to be 
piezoelectric at low frequencies when dry, hydrated collagen is only piezoelectric at much 
higher frequencies, (Reinish and Nowick, 1975) and furthermore an electrical charge may 
stimulate skeletal repair and osteoblastogenesis (Goldstein et al., 2010; Noris-Suarez et al., 
2007).  Interestingly, Hakansson notes that one of the innate biological resonances of the 
protein complexes and minerals forming bone was found to be at an average of 972 Hz 
(Hakansson et al., 1994); it can hence be argued that this frequency is too close to one of the 
nanokicking frequencies we have employed (i.e. 1000 Hz) to simply be a biological 
coincidence.   
After 7 days of mechanical stimulation, a marked increase in osteogenic related genes was 
observed, as the frequency was increased to 5000 Hz. The genes observed to be most 
up-regulated were OPN, OCN, ONN and osterix, with RUNX2 and BMP2 being less 
up-regulated at this time point. This osteoblastogenic genetic timeline is logical as BMP2 
mediates RUNX2 (Jang et al., 2012; Kopf et al., 2012; Phimphilai et al., 2006) and RUNX2, 
which is a master transcription factor of osteogenesis (Gaur et al., 2005), proceeds to facilitate 
the increase of these later osteogenic genes like osterix (also an osteogenic transcription 
factor) and OCN, and is then itself down-regulated, as per the accepted transcript 
chronological order of osteogenesis see (Figure 1.3) (Stein and Lian, 1993).  
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It could be further argued that an increase in frequency also provides an increase in the force 
(through acceleration, where by force = mass of media above the cells × acceleration) being 
transmitted to the cells, which were adhered to the surface of the substrate. This would mean 
that as frequency increased the cells would, in effect 2D speaking, feel more ‘gravity’ and 
increasing gravity can be osteogenic (Holick, 1998; Miyamoto et al., 1998).  
 
While in agreement that nanokicking was stimulatory to osteogenesis, the results at a 
transcript and protein level were a little out of sync. The transcriptional data indicated that 
nanokicking induced osteogenic gene transcription, but the response was generally not large 
apart from at 5000 Hz at the early time point assessed (7 days). It could be argued that this is 
perhaps from the extra amplitude predicted from the ANSYS modeling and tested resonant 
frequencies at the substrate edges at 5000 Hz, previously described in chapter 2, data provided 
in (Figures 2.5 and 2.7). It is noteworthy, that although the extra amplitude most likely 
caused by a resonant frequency at 5000 Hz provides a strongly positive osteogenic transcript 
response; due to lack of control and reproducibility of amplitude displacement, (from internal 
resonances), it would make consistently using a vibrational bioreactor calibrated to 5000 Hz 
challenging.  
 
Perhaps surprisingly, it was observed that adding the nanotopography suppressed the 
nanokicking effect at this early transcriptomic time point (Figure 3.3 A-F). However, protein 
level assessment at 21 days showed that nanokicking was more stimulatory than topography 
alone and that topography and nanokicking together could have an augmentative effect. This 
was confirmed by mineralisation assessment where topography and nanokicking both led to 
mature nodule formation, relative to the other conditions assessed, and the nodule formation 
was increased where both nanokicking and topography were used concomitantly. The protein 
level data and mineralisation data both also suggested that there was little extra osteogenic 
effect observed by using frequencies higher than 1000 Hz.  
 
It is further interesting to note that without nanokicking, osteoinductive media and NSq-50 
mostly induce OPN expression. However, whenever nanokicking is employed with or without 
the NSq-50 surface, OCN then assumes the most abundant expression. This could perhaps be 
explained by the fact that OPN, as well as aiding in binding of calcium, is also an 
Arg-Gly-Asp (RGD) containing glycoprotein which facilitates cellular adhesion (Bautista et 
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al., 1994; Zou et al., 2013). While OCN on the other hand, simply aids in bone mineralisation 
(Lee et al., 2007). One hypothesis is that nanokicking may potentially alter cell integrin 
attachments and potentially negate the need for additional RGD groups. This finding lends 
itself to work by Pierres et al demonstrating that cells vibrate on the nanoscale as they adhere; 
i.e. we supply the cells with nanoscale vibration and adhesion occurs via a different route 
compared to static samples (Pierres et al., 2008; Pierres et al., 2009).  Also as an observation 
it is appealing that, as would be expected, proteins like OCN and OPN when immunostained 
were generally found around the Golgi apparatus and endoplasmic reticulum (sites of protein 
manufacture) before subsequently being transported to the extracellular matrix for use in 
mineral binding and cell attachment (Figure 3.4 B). Further still it appears that ROCK/(RhoA 
kinase) pathway is involved and important for osteogenesis brought about through 
nanokicking further suggesting an adhesion dependant mechanism as the pathway can also be 
stimulated through the focal adhesions (Nikukar et al., 2013). 
 
3.5   Conclusion  
As would be expected from the canonical flow of biological data, an up-regulation of 
transcriptomics would lead to an up-regulation of proteins and subsequently a biological 
product, which in the case of osteogenesis would be Ca10(PO4)6 deposition or the initial stages 
of the formation of mineralised bone (an osteon). This was the rationale used to determine if 
high frequency piezo vibrations (nanokicking) coupled with the also osteogenic 
nanotopographical surface (NSq-50) could augment the osteogenic phenotype. The data gave 
an affirmative result to this question and it was observed that an up-regulation of genes and 
proteins related to osteogenesis was determined; culminating with circular mineral Ca10(PO4)6 
deposits varying from 100 – 300 µm in diameter. Nano-kicking in its own right at a frequency 
of 1000 Hz was observed to be the most strongly osteogenic and when coupled with the 
NSq-50 surface also had a combined effect at the protein and most importantly at the 
mineralisation level. These positive data, grant confidence in the ability of high frequency 
vibrations resulting in nanometre level displacements, (driven by a piezo actuator) to 
stimulate MSCs to differentiate into osteoblastic cells, on a 2D surface. 
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4.1  Introduction 
The work performed in chapter III, confirmed the ability of nanokicking (piezo technology) to 
bring about osteogenesis in 2D, and this was validated through genetic, protein and 
mineralisation results. Following on from this, the question was asked, could this technology 
i.e. nanokicking also be osteogenically inductive in 3D?  
To facilitate finding an answer to this question a new reproducible and efficient bioreactor 
had to be developed and tested, which could harbour a 3D matrix such as collagen, in which 
MSCs could be grown. This would hence provide an in vitro /ex vivo bioreactor with cells 
grown more in line with the in vivo state. In the first instance it would be necessary to test and 
validate this new bioreactor once again, before initiating 3D osteogenic experiments. 
4.2  Materials and methods 
4.2.1  Materials 
Note: Several of the reagents, protocols and the materials listed in chapter II were also 
prepared in the same fashion for chapter IV; as a result these have not been relisted in (Table 
4.1). Only new methods, protocols and reagents distinctive to chapter IV have been listed in 
(Table 4.1) and have been explained throughout section 4.2.  
Materials and Reagents Source / Supplier/ Prepared 
Collagen Type 1 (Rats Tail) – 2.05 mg/mL First Link UK, B/N:RTC6783, Cat: 60-30-810 
10 X DMEM First Link UK, B/N:MEM5813, Cat: 60-91-810 
0.1 M NaOH Fluka 72079-500mL, Lot: BCBL7951 
Bovine serum albumin (FBS) Fisher Scientific – BP9700-100 Lot: 61-1247 
DMEM Sigma Life Sciences, DR671, Lot:RNBD4946 
Phosphorylated RUNX2 antibody – Rabbit  Abgent Cat no. Ap3559a, Lot: PS465 
Laser inteferometer SP-S, SIOS Meßtechnik GmbH, Ilmenau, Germany 
Biotinylated anti-rabbit IgG (H+L) Vector Laboratories BA-1100, Lot: W0614 
Fluorescein streptavidin Vector Laboratories SA-5001, Lot: W0408 
Piezo actuator Physik Instrumente, Karlsruhe, Germany – 
PL088.30 
3 mm  Fe2O3 ferrite magnets (700 gauss – 
0.07T) 
Magnet Expert, Tuxford, UK – F356F 
6 well cell culture cluster Corning Incorporated 3516, NY 
Signal generator Agilent, 33210A, CA  
High voltage piezo driver amplifier ENV 150, Piezosystemjena, Jena, Germany 
Table 4.1: List of materials and reagents used in chapter IV
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 4.2.2  Setup/design of functioning novel bioreactor  
As with the previous set up, an Agilent 33210A function generator served as the power 
source. However, to facilitate the new design a new model piezo actuator was required 
(PL088.30) and this meant that an amplifier (ENV 150) was also necessary for use along with 
the signal generator in order to give a voltage output of up to 80 V (160 V being the 
maximum voltage available). The continuous sinusoidal sine wave ranged between - 10 V to 
+ 70 V, (80 V) in total and this caused 13 piezo actuators moving in unison to provide 
nano-displacement of the entire top platform of the new bioreactor design. The top plate of 
the platform was made of grade 420 magnetic stainless steel. On top of this the 6 well plate 
used to culture the cells had 6 x 30 mm Fe2O3 ferrite magnets adhered to the outside bottom 
(using 2 part epoxy glue – Henkel Dusseldorf, Germany). The 6 well plate was then 
magnetically attached to the top platform of the bioreactor.  
An aluminum block served as the base of the bioreactor and facilitated the transference of the 
nanokicking displacements upwards instead of outward into the ambience. See (Figure 4.3 A 
& C) for the bioreactor design and setup along with (Figure 4.3 B) for an aerial view of the 
collagen gel seeded with cells in the 6 well plate, chapter IV results section. 
 
4.2.3  Cell culture and media preparation 
See section 2.3.4 page 36, for the methodology which was used to culture and feed the cells 
for the piezo samples. Although the cell culture preparation was the same, the duration which 
the experiments were carried out for was differed depending on whether it was transcriptional, 
protein or calcium phosphate mineralisation which was being assessed. To feed the MSCs that 
were cultured in the 3D collagen gels the bioreactor was carefully tilted to the side and the 
previous media was removed using a sterile pipette. Each individual well was then 
replenished with approximately 2 mL of fresh media. The media was changed every 3 – 4 
days. 
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4.2.4  Quantitative real-time (qRT-) PCR 
See section 2.3.7 of chapter II, pg 40 for the methodology and preparation steps used to 
harvest the cells after experimental culture, and to isolate and quantify the mRNA. (Table 
4.2) below lists the specific gene primers which were used to perform the quantification 
experiments. GAPDH served as the house-keeping gene against which the relative presence of 
all the other genes (mRNA) listed in (Table 4.2) were quantified.  
After 8 days of nanokicking MSCs cultured in either 6 or 24 well plates were assessed by 
qRT-PCR. The MSCs were harvested using trypsin and mechanical scrapping. The total RNA 
content was then extracted and DNase treated to remove any DNA present. For all sample 
conditions the RNA of three material triplicates were harvested using the Qiagen RNeasy 
extraction kit. The RNA content was quantified using the nanodrop system UV 
spectrophotometer and the levels of all samples were normalised. Following this the RNA 
was reverse transcribed to cDNA using the Qiagen quantiscript reverse transcription kit. The 
amplification of the cDNA was then carried out using the SYBR green PCR Kit.  
Two frequencies (1000 Hz and 4000 Hz for both 6 and 24-well plates), with seeding 
performed at ~ 6,000 cells per well for the 24 well plates and ~25,000 cells per well for the 6-
well plates were assessed. The plates were attached to the vibrational platform via magnets. 
(Note: 4 of the wells on the 24 well plate were combined to give one sample). The strength of 
the magnets was 0.07 T and a static magnetic field was only employed on the side of the 
vibrational surface i.e. not towards the cultured cells.  
Given the strength of the magnets used and the setup which was employed, the weak 
magnetic field was expected to have negligible if any biological effect (Miyakoshi, 2006).  
Note: these qRT-PCR experiments were performed in 2D as it was necessary to first perform 
bioequivalence testing of the new bioreactor, and confirm osteogenesis in 2D before 
progressing to 3D collagen gel experiments. 
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Table 4.2: Sequence for the qRT-PCR gene primers used. 
4.2.5  Immunofluorescence procedure 
• After 3 days piezo stimulation at 1000 Hz, the cells were rinsed with 1 x PBS wash 
buffer. 
• A solution of 38% formaldehyde was then used to fix the MSCs inside the 6 well 
plate. This was performed at 4˚C for 5 minutes. 
• Permeablising buffer was used to permealise the cells, and the wells were submerged 
and incubated at 37˚C for 5 minutes.  
• PBS/1%BSA was used as a blocking agent and the wells were first incubated in the 
blocking buffer for 5 minutes at 37˚C. The solution was removed and a primary 
antibody, rabbit, specific to phosphorylated RUNX2 was added, the samples were 
incubated at 37˚C for 1.5 hrs.  
Gene Forward Primer Reverse Primer 
GAPDH TCAAGGCTGAGAACGGGAA TGGGTGGCAGTGATGGCA 
Alkaline 
Phosphatase 
ATGAAGGAAAAGCCAAGCAG CCACCAAATGTGAAGACGTG 
RUNX2 GGTCAGATGCAGGCGGCCC TACGTGTGGTAGCGCGTGGC 
Osterix GGCAAAGCAGGCACAAAGAAG AATGAGTGGGAAAAGGGAGGG 
Osteonectin AGAATGAGAAGCGCCTGGAG CTGCCAGTGTACAGGGAAGA 
Osteocalcin CAGCGAGGTAGTGAAGAGACC TCTGGAGTTTATTTGGGAGCAG 
PTK2 GTCTGCCTTCGCTTCACG GCCGAGATCATGCCACTC 
MAP2K1 TTTTAGGAAAAGTTAGCATTGCTGT AGGGCTTGACATCTCTGTGC 
MAP2K2 ACCAAAGTCCAGCACAGACC ATGATCTGGTTCCGGATGG 
ERK1 CCCTAGCCCAGACAGACATC GCACAGTGTCCATTTTCTAACAGT 
ERK2 TCTGCACCGTGACCTCAA GCCAGGCCAAAGTCACAG 
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• The primary antibody was then removed and the samples were washed for 3 x 5 
minutes using the wash buffer (1 x PBS). The final wash was performed with agitation 
on a shaker. 
• The secondary antibody, biotinylated anti-rabbit, was then added and the samples were 
incubated at 37˚C for 1 hour. 
• The secondary antibody was removed and the samples were once again washed for 3 x 
5 minutes using wash buffer, with the last wash being performed with agitation.  
• The wash buffer was removed and tertiary complex, fluorescein streptadivin, was 
added. The samples were then wrapped in foil and incubated at 4˚C for 30 minutes. 
• The tertiary complex was removed and the same wash procedure was once again 
undergone. 
• Following on from this, a small drop of vectroshield-DAPI (to stain the nucleus) was 
added to the sample and a microscope coverslip was placed into the well.  
• Microscopy was performed using an Axiophot-Zeiss, Germany. 
 
4.2.6     Preparation of collagen gels 
Collagen gels were prepared by adding collagen, which was acidic in nature, to 0.1 M NaOH 
in order to perform an acid base (phenol red indicator) titration. The change of pH towards a 
neutral level, caused self assembly or 3D rearrangement of the collagen structure to become 
more branched and cross linked in nature (Pogorelov and Selezneva, 2010). The gels were 
prepared by keeping a constant ratio between all reagents which would be used. This was as 
follows: 
• Collagen - 40% total volume 
• FBS – 8% total volume 
• 10 X DMEM – 8% total volume 
• Cells in media (basal media) – 8% total volume (A predetermined amount of cells 
(100,000 or 200,000 per well in a 6 well plate) was prepared by trypsinisation and 
counting using a hemocytometer. The cells were then resuspended in basal media. 
• 0.1% NaOH - ~ 36% total volume 
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In the first instance the FBS, collagen and 10 X DMEM were added together and kept on ice. 
The cells in media were then added to the solution while being kept on ice. Following this the 
0.1% NaOH was added, quickly at first and then drop wise, while stirring the solution until a 
permanent pink colour was observed. While kept on ice the gels were then added to the 
predefined 6 well plates which were used for the experiment. The gels were then quickly 
transferred to an incubator and allowed to set as increasing temperature further caused self 
assembly of the collagen 3D matrix. Four hours were allowed to elapse until nanokicking was 
initiated and the following day ~ 2 mL of fresh media was added to each well.  
4.2.7  Laser vibrometry and nanokicking 3D characterisation 
Laser interferometric vibrometry was again used to characterise the novel bioreactor with 
collagen gels used as a medium in which cells could be grown in 3D. See section 2.3.5, for an 
explanation of the laser vibrometer set up and use.  
 
The aim of the new bioreactor set up was to enable the transference of the nanoscale 
vibrational stimulation from the piezo actuator through collagen gels in a 6 well plate. The 
collagen gels were rigid enough to allow a thin sheet of silica mirror to be placed on top of the 
gel. The laser from the interferometer could then be reflected from the top of the activated 
bioreactor to determine if the piezo driven nanoscale excursions could be permeated through 
the gels, and subsequently if the MSCs cultured within the gels in 3D, could also be 
stimulated by the nanokicking vertical vibrations. To assess this, and to concurrently 
characterise the novel 3D bioreactor system, two gel fills were determined; i.e. 2.5 mL and 
5.0 mL and the nanoscale displacements were measured at the centre and at the corners of 
individual wells, within the 6 well plate.  
 
The measurements were assessed (and the 3D bioreactor hence calibrated) at the varying 
voltages of 16, 32, 48, 64 and 80 V, and at the varying frequencies of 500, 1000, 2000, 3000 
and 4000 Hz to determine if the 3D gel displacements were linear and consistent. A cell 
population of 100,000 cells per each well was used for the 2.5 mL collagen gel fill and 
200,000 cells for the 5.0 mL collagen gel fill. The analyses were performed in triplicate with 
different wells being assessed. The assessment was performed at varying frequencies from 
500 to 4000 Hz, determining both the centre and edge mean displacements for both the 2.5 
and 5.0 mL collagen gel fills.  
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The nanometre displacements were taken at varying frequencies from 500 Hz to 4000 Hz but 
the amplitude was measured at 80 V. 80 V was the amplitude used for 3D piezo vibrational 
stimulation.  
 
4.3  Results 
4.3.1  Bioequivalence – The confirmation of nanokicking induced 
osteogenesis by the new platform in 2D  
The first experiments on the new bioreactor were to determine if it in fact was able to induce 
osteogenesis in MSCs in 2D, and what’s more to investigate what the optimum condition to 
do this was; i.e. would it be with use of a 6 well plate or a 24 well plate and would it be at 
1000 Hz or 4000 Hz. To gain an answer to this question, in the first instance the technique of 
qRT-PCR was employed to assess any potential change in osteogenic transcripts between 
different sample sets of nanokicked samples and controls.  
Nanokicking was performed for 8 days, and mRNA from unstimulated controls was used to 
assess the prevalence of the increase in osteogenic genes through the high frequency 
vibrations. So as to maintain consistency through the experiment and reduce variability the 
controls were also cultured with magnets beneath the plates, but were not stimulated by 
nanokicking.  
The four osteogenic genes assessed included osterix, ALKP, OCN and ONN. At 1000 Hz in a 
6 well plate all four genes were increased, with the gene ALKP encoding for alkaline 
phosphatease and the bone gamma carboxyglutamate protein (BGLAP) i.e. the gene coding 
for OCN showing significance relative to the controls, (Figure 4.1 A). 1000 Hz vibration with 
a 6-well plate and 4000 Hz vibration with a 24 well plate respectively provided the best 
results, and incidentally these conditions are also most in line with the up-regualtion of the 
genes related to the ERK/MAPK pathway, (Figure 4.2 A), and hence it is deemed will 
provide the most reproducible biological results. OCN is secreted mainly by osteoblasts and 
OCN is solely involved in bone mineralisation (Lee et al., 2007), which supports the 
prevalence of osteoblast differentiation using this vibrational bioreactor. Note both the 6 and 
24 well plate experiments used the 30 mm diameter magnet in order to observe if one magnet 
type could be used with various plates. This may have also affected the results observed while 
using the 24 well plate. 
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On the contrary, the MSCs cultured in a 24 well plate with a 1000 Hz vibration, showed 
almost no up-regulation of the same osteogenic genes and the MSCs cultured at 4000 Hz with 
the 6-well plate provided a less consistent stimulation of these genes, albeit significant only 
ONN and ALKP were observed to be up-regulated out of the 4 genes assessed. 
 
Figure 4.1: qRT-PCR for mRNA gene expression – Transcriptional Analysis. MSCs were 
nanokicked on the vibrational bioreactor for 8 days. (A) The MSCs were nanokicked at a 
frequency of 1000 Hz in a 6-well plate, (B) The MSCs were nanokicked at 1000 Hz in a 24 
well plate, (C) The MSCs were nanokicked at 4000 Hz in a 6-well plate, (D) The MSCs were 
nanokicked at 4000 Hz in a 24 well plate. The subsequent gene expression of osterix, ALKP, 
osteocalcin and osteonection were assessed relative to an unstimulated control. All 
experiments were carried out at an amplitude of 80 V with a 22 nm vertical displacement. N = 
3, results are mean ± standard deviation *p < 0.05 and **p < 0.01 by unpaired T-Test. 
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4.3.2  Biological mechanism of nanokicking induced osteogenesis 
It was noteworthy to understand to some extent, how or by which mechanism nanokicked 
linked osteogenesis would occur. Although there undoubtedly are other pathways, it was 
believed that ERK/MAPK pathway would be critical.  
After 8 days of nanokicking at 1000 Hz and 4000 Hz with cells seeded in a 6 and 24-well 
plate; qRT-PCR was used to determine the levels of the gene PTK2 encoding for focal 
adhesion kinase (FAK) relative to an unstimulated control and this was found to increase. 
Following the mechanistic cascade; other genes along the ERK/MAPK pathway including 
extracellular signal regulated kinases (ERK 1 and 2) showed an elevated expression. The 
activities of ERKs are linked to mitogen activated protein kinases (MAPKs) and 
subsequently, MAP2K1 and MAP2K2 were also observed to be up-regulated with MAP2K1 
showing a significant increase in (Figure 4.2 A), i.e. the stimulation of MSCs in a 6 well plate 
at 1000 Hz.  
A downstream effector of this mechanistic cascade; i.e. the activated protein form of the 
osteogenic transcription factor phosphorylated RUNX2 (pRUNX2) was assessed by 
immunostaining, and unsurprisingly this too showed up-regulation after 3 days of 
nanokicking in a 6-well plate at 1000 Hz. (Figure 4.2 I) clearly showed the greatest increase 
being in or around the nucleus of the nanokicked MSCs.  
The samples cultured at 4000 Hz in a 6 well plate and 4000 Hz in a 24 well plate showed only 
a negligible increase in the genes assessed related to the ERK/MAPK pathway and it was 
clear that this frequency was not MAPK inductive at the transcriptional level. The MSCs 
cultured at 1000 Hz in a 24 well plate also showed an equivalent increase of these genes 
relative to the samples at 1000 Hz in a 6 well plate, however, the standard deviations between 
the samples was much larger which meant less reproducible results (Figure 4. 2 B). Of 
importance was the fact that the MSCs cultured at these conditions (1000 Hz in a 24 well 
plate), and assessed for osteogenesis showed almost no increase of any of the genes related to 
osteogenesis, (Figure 4.1 B), i.e. at this condition (1000 Hz with a 24 well plate) a genetic 
up-regulation of MAPK and osteogenesis did not correlate.  
On the contrary however, as was the case above with the osteogenic related genes, the results 
in (Figure 4.2 A) showed that the ideal condition for the increased expression of the 
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MEK/MAPK transcriptomics was from MSCs stimulated in a 6-well plate at a frequency 
1000 Hz, i.e. the condition of 1000 Hz in a 6 well plate provided concurrent MAPK and 
osteogenic up-regulation confirming this to be the optimum condition. 
 
 
Figure 4.2: qRT-PCR for mRNA gene expression - Transcriptional Analysis. MSCs were 
nanokicked on the vibrational bioreactor for 8 days. (A) The MSCs were nanokicked at a 
frequency of 1000 Hz in a 6-well plate, (B) The MSCs were nanokicked at 1000 Hz in a 24 
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well plate, (C) The MSCs were nanokicked at 4000 Hz in a 6-well plate, (D) The MSCs were 
nanokicked at 4000 Hz in a 24 well plate. The expression of genes related to the, ERK/MAPK 
pathway, believed to be pivotal for mechanotransductive initiated osteoblastogenesis brought 
about through nanokicking; i.e. PTK2 (coding for FAK), ERK 1 and 2, MAP2K1 and 
MAP2K2, were assessed relative to an unstimulated control. All experiments were carried out 
at an amplitude of 80 V with a 22 nm vertical displacement. N = 3, results are mean ± 
standard deviation *p < 0.05 by unpaired t-test. (E & G): Immunostaining for phosphorylated 
RUNX2 for controls T1 and T2 after 3 days, showing unstimulated or basal levels of protein 
expression of phosphorylated RUNX2, (F & H) Immunsotaining for phosphorylated RUNX2 
for nanokicked samples stimulated at 1000 Hz in a 6-well plate, T1 and T2 showing an 
increased expression of phosphorulated RUNX2 caused by high frequency nanokicking, Mag 
20×, scale bar =100 µm. Fixed cells were stained for pRUNX2 (green), N = 2. (I) The 
subsequent quantitative representation of pRUNX2 immunostaining intensities, 1000 Hz 
piezo stimulated in a 6-well plate relative to the control with no stimulation, N=2. 
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4.3.3  Characterization of the new vibrational bioreactor using 3D 
collagen gel as an extracellular matrix 
The parameter setting results for the new bioreactor performed in 2D showed that the optimal 
osteogenic condition for the bioreactor was at 1000 Hz using a 6 well plate. As a result of this 
the next set of experiments involved characterising the collagen gel with nanokicking using 
those conditions. The bioreactor and interferometer were set up as described in section 4.2.2 
and (Figure 4.3 A-C). 
Collagen gel fills at 2.5 ml and 5.0 mL were compared using intereformetry to determine the 
level of displacement in a vertical direction. The data showed that when assessing 500, 1000, 
2000, 3000 and 4000 Hz against amplitudes of 16, 32, 48, 64 and 80 V the nanolevel 
displacements were, in fact, linear for both 2.5 mL and 5.0 mL gel fills at each of these 
frequencies.  
At 1000 Hz the 5 mL gel fill gave displacements which were on average 1/3rd that of the 2.5 
mL gell fills. The maximum amplitude of 80 V providing a displacement of 5 nm for the 5 
mL collagen samples and 15 nm for the 2.5 ml collagen samples. Average displacement were 
observed at approximately 3 nm and 1 nm, for 2.5 and 5.0 ml collagen gel fills respectively at 
the lowest amplitude of 16 V (Figure 4.4 A & B).  
In order to understand the uniformity of the displacement across the entire surface of a well, 
interferometric measurements were taken at the centre and also at the edge of the gels for both 
2.5 mL and 5.0 ml samples. The data gave evidence that any change between the centre and 
edges at the 1000 Hz frequency was negligible. At 80 V the 2.5 ml gels gave a displacement 
of approximately 15 nm (Figure 4.5 C&D) at both the centre and edges and this was the case 
when the mean data from both the edges and centre samples were combined, see (Figure 4.5 
A). The 5.0 mL gels gave a displacement at approximately 5.0 nm at 80 V for both the 
individual mean centre and edge values (Figure 4.5 E&F) and also approximately 5.0 nm for 
the centre and edge mean combined results (Figure 4.5 B). 
 
It is noteworthy that at the frequency of 3000 Hz a change in displacement was observed 
between the centre and edges, at both 2.5 and 5.0 mL gel fills with the edges showing an 
increased displacement with large SD, albeit the 5.0 mL edge displacements showed more 
variance than the 2.5 mL gel fill, see (Figure 4.5 A-F).  
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Figure 4.3: The nanokicking 3D collagen gel bioreactor (A) bioreactor set up for interferometric 
measurement, (B) aerial view of the 3D bioreactor showing the collagen gels set in a 6 well plate with 
the interferometric laser being shone over the gels for measurement, a silica mirror is used to reflect 
the laser for measurement, note: magnets were adhered to the outside of the 6 well plate to 
magnetically attach the 6 well plate to the surface, (C) cross sectional view of the 3D bioreactor 
showing the 6 well plate with 5 mL collagen gel fill, on top of the vibrational platform. 
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Figure 4.4: Summary collagen gel (centre and edges) interferometric measurements showing 
change in displacement (nm) relative to voltage at a particular frequency. (A) assessment 
performed on a 2.5 ml collagen gel fill (B) assessment performed on a 5 mL collagen gel fill. 
N = 6 piezo actuators (3 edge and 3 centre piezo actuators with 5 measurements for each 
piezo actuators). Frequencies assessed were 500, 1000, 2000 and 4000 Hz and mean 
measurements appeared to be linear across voltages measured i.e. 16, 32, 48, 64, and 80 V. 5 
ml gel fills = 200000 MG-63 cells and 2.5 ml gel fills = 100000 MG-63 cells. 
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Figure 4.5: Collagen gel interferometric measurements for the 3D bioreactor, displacments 
were measured in 6 well plates (A) Summary of the edges and centre displacement in nm for a 
2.5 mL gel fill  (B) Summary of the edges and centre displacement in nm for a 5 mL gel fill. 
(C) 2.5 mL gel fill meansurements for centre only. (D) 2.5 mL gel fill measurements for edges 
only. (E) 5 mL gel fill measurement for centre only (F) 5 mL gel fill measurement for edges 
only. Voltage used was 80 V, Frequencies assessed were 500, 1000, 2000 and 4000 Hz. N = 6 
piezo actuators for A-B, and N = 3 piezo actuators for C – F, with 5 measurements for each 
actuator, 5 mL gel fills = 200000 MG-63 cells and 2.5 mL gel fill = 100000 MG-63 cells. 
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4.4  Discussion of Results 
The biological data from the parameter or specification setting experiments suggested that 
efficient and reproducible osteoblastic differentiation of MSCs occurred best using a 6-well 
plate at a frequency of 1000 Hz. This was confirmed through the 2D bioequivalence 
experiments, which proved that the previous and new bioreactor designs were osteogenically 
comparable. See Chapter II section 2.3.3, (Figure 2.2) for the previous design and 
characterisation of the bioreactor and (Figure 4.3 C) for the new design.   
The interferometric data provided in (Figure 4.4) and (Figure 4.5) proves that having a 
magnet placed under each well relays a consistent uniform displacement 
mechanotransductively, which can then be biologically interpreted by the cultured cells as a 
cue for differentiation. This is not only confirmed by the osteogenic transcript data but also by 
the ERK/MAPK transcript data, which correlates well providing further confidence (Celil and 
Campbell, 2005; Zhu et al., 2012a). The fact that we have observed an increase in all the 
genes investigated related to the ERK/MAPK pathway, (Figure 4.2 A) at a transcriptomic 
level is reassuring, especially when the true biological expression of the ERK/MAPK 
pathway is observed at the protein level after post translation modification, primarily due to 
phosphorylation (Burack and Sturgill, 1997).  
The mitogen activated protein kinase pathway is very important for cell division and hence 
proliferation, but here it appears that the downstream effector of this pathway is an 
up-regulation of pRUNX2 and hence osteogenic differentiation. This useful data provides us 
with not only a proof of concept for nanokicking induced osteogenesis, but we also begin to 
gain a preliminary understanding of a potential mechanism. It is worth stating however, that 
other mechanisms too such as the ROCK/RhoA pathway have also appeared to be 
fundamental (Xiao et al., 2002) (Nikukar et al., 2013).  
Interestingly, the increase in intensity of the pRUNX2 at the protein level was observed at 3 
days to be strongly centred around the nucleus of the cells. This too is logical as one would 
expect a transcription factor to be located near and around the nucleus, where it can facilitate 
promotion of the cells genetic machinery. This would cause a further up-regulation of other 
bone specific genes such as osterix and OCN, which is important for the binding and 
deposition of calcium and hence hydroxyapitite mineralisation (Lee et al., 2007). 
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The characterisation of the collagen gels with the new setup showed that the 5 mL gel fill had 
a displacement at 1/3rd that of the 2.5 mL gel fill, no doubt due to the increased height of the 
gels absorbing and dissipating the effect of nanokicking. This data guides the use of the new 
bioreactor towards the 2.5 mL collagen gel fill for 3D experiments, as the inteferometry 
shows this would still give a displacement at 1000 Hz equivalent of 15 nm (Figure 4.5).  
The unusually high displacements observed at 3000 Hz and 2000 Hz for the 2.5 mL and 5 mL 
gel fills could be attributed to innate resonances for the bioreactor. While this may provide an 
extra-vibrational effect it is believed that this would limit control and reproducibility in future 
piezo osteogenic experiments, hence is was decided that these frequency although perhaps 
strongly osteogenic would be inconsistent and provide limited control, an aspect that would 
not be tolerated under GMP conditions.  
4.5  Conclusion  
Through the use of interferometry, transcriptional and protein profiling related to osteogenesis 
in this chapter, I have confirmed the osteogenic capability of a novel bioreactor in 2D. What’s 
more I have also confirmed that these sinusoidal waves can be transmitted through a collagen 
gel matrix to the surface providing evidence that 3D cultured MSCs would be exposed to this 
stimulation.  
The bioreactor has been calibrated to 1000 Hz and 80 V, with a 3D collagen gel fill of 2.5 
mL. This protocol will subsequently deliver a vertical displacement in the region of 15 nm. 
The next steps are now to assess this bioreactor in situ, cultured with MSCs in the 3D 
collagen matrix. This will be more closely aligned to their in vivo innate environment (ex 
vivo). The possibility of the differentiation of osteoblasts, and hence the formation of mineral 
deposits will be determined, i.e. if it is feasible to use this bioreactor to artificially engineer, in 
3D, autologous human osteoblasts and calcium phosphate mineral deposits. 
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5.1  Introduction 
The majority of the research related to regenerative medicine to date has centred on 2D 
culture experimentation, and although granting great insight, for the most part this research 
has been limited to cell engineering (Biggs et al., 2009; Huang et al., 2013; Peytour et al., 
2013). It is evident that in order to truly harness the full potential of stem cells and to 
artificially grow and engineer tissue or organs, a knowledge and understanding of 3D culture 
is required (Petersen et al., 2010; Uygun et al., 2010). Classical osseous engineering attempts 
have utilised a source of osteogenic cells, a matrix material and the use of growth factors and 
osteogenic differentiation media such as dexamethasone and BMP-2 or other members of the 
transforming growth factor beta (TGF-β) superfamily (Xie and Han, 1996). When it comes to 
efforts made in the use of osseous bioreactors; maintenance of long term sterility, cost and 
difficulty operating present perfusion, spinner and rotating designs, as well as difficulties in 
clinical implementation have meant so far success in skeletal regenerative medicine has been 
limited (Laffosse et al., 2010; Langer et al., 2009; Rauh et al., 2011b). As a result, autografts 
and allografts, despite often being inadequate, have remained the best treatment available to 
clinicians.  
It is of benefit to appropriate biomimetics in a potential matrix which can assume the 
physiological or mechanical characteristics of the in vivo natural state.  In research into 
osteogenesis, be it endochondral or intramembranous bone formation, MSCs take a central 
role due to their mesodermal differentiation potential (Caplan, 1991; De Ugarte et al., 2003a). 
In bone tissue engineering the use of scaffolds or matrices which are osteoinductive or 
osteoconducive is the goal of biomimetics. To induce osteogenesis in 3D using MSCs an 
excellent matrix scaffold choice has been found to be Type I collagen (COL I). As far as 
osteo-biomimetics it is uniquely placed as greater than 90% of the organic composition of 
bone is made up of COL I. What’s more like fibronectin, COL I also possesses the RGD 
(arginine-glycine-aspartic acid) adhesion sequence recognised by cell integrins, aiding not just 
cell attachment and migration but also proliferation. Further still an increased expression of 
mRNA and proteins related to OCN, OPN, ONN and COL I are almost a definitive indication 
of MSCs commitment to form osteoblasts. In particular OCN is directly regulated by the 
master transcription factor RUNX2, and is osteoblast specific, being secreted for calcium 
binding and deposition in bone modelling (and re-modelling in tandem with osteoclasts) (Lee 
et al., 2007; Weinreb et al., 1990). 
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Previously, it has been proven throughout this thesis and also published (Nikukar et al., 2013), 
that by mechanotransduction, nanokicking – i.e. high frequency low amplitude (nm scale) 
sinusoidal displacements can induce MSCs on a 2D surface to differentiate into osteoblasts. 
However, due to the limitations of 2D culture this work has been restricted to the 
development of an osteoblastic bioreactor. Collagen, as a 3D biomimetic matrix, has the 
potential to move towards bone tissue engineering. Interestingly, Sumanasinghe et al have 
researched the effect of uniaxial cyclic tensile (mechanical) strain on MSCs in a collagen 
construct and have found this to induce osteogenesis (Sumanasinghe et al., 2006). In line with 
this premise further work has shown that spontaneous osteogensis of MSCs cultured in a COL 
I matrix can also be achieved by simply altering the cytoskeletal tension of the gel (Kon et al., 
2009). Also of note, very recent research has been performed using scaffolds composed of 
nanoparticulate mineralised collagen glycosaminoglycan, which was found to be osteogenic 
in its own right without the requirement of BMP-2 compared to controls. The success of this 
scaffold appeared to be in harmonising the combination of both the organic as well as the 
inorganic counterparts of bone (Ren et al., 2015).  
In this chapter it is hypothesised that nanokicking MSCs cultured in a 3D collagen 
extracellular matrix, can in vitro, grow calcium phosphate (Ca10(PO4)6) hydroxyapatite 
nodules in situ. These MSCs have been deliberately cultured without the addition of soluble 
factors or osteogenic chemical stimulation to singularly assess the osteogenic potential of 
nanokicking. This was achieved by engineering the novel vibrational osseous bioreactor 
already discussed in chapter IV. To interrogate this theory cultured MSCs were nanokicked 
and assessed at a genetic, protein and quantitative mineralisation levels relative to 
unstimulated controls (MSCs cultured in a collagen matrix which were not nanokicked).  
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5.2  Materials and methods 
5.2.1  Materials 
Materials and Reagents Source / Supplier 
Human mesenchymal stem cells, from bone 
marrow 
Promocell GmBH, Germany 
Collagen Type 1 (Rats Tail) – 2.05 mg/mL First Link UK, B/N:RTC6783, Cat: 60-30-810 
10 X DMEM First Link UK, B/N:MEM5813, Cat: 60-91-810 
0.1 M NaOH Fluka 72079-500mL, Lot: BCBL7951 
Bovine serum albumin (FBS) Fisher Scientific – BP9700-100 Lot: 61-1247 
Osteocalcin mouse monoclonal IgG antibody Santa Cruz Biotechnology, ABOC-5201, Lot: 
G3014  
Osteopontin mouse monoclonal IgG antibody Santa Cruz Biotechnology, AKM2A1 Lot:G1613 -  
GAPDH rabbit monoclonal antibody  Abcam, ab128915, LotGR179384-1 
anti-mouse IRDye 680 CW LI-COR 926-68077 
anti-rabbit IRDye 800 CW LI-COR 926-32213  
Rnase free water Qiagen, UK 
Quantitech reverse transcriptase kit Qiagen, UK 
Spectrophotometer Nanodrop ND-1000 
7500 Real time PCR system Applied Biosystems – S/N:275007079 
Trizol  Life Technologies 15596-026 
Chloroform Sigma Aldrich 288306-100ML 
Triton X-100 Sigma S/N:T-9284 
Tween 20 Sigma Aldrich P9416-100mL 
Permeability buffer Centre for Cell Engineering, University of Glasgow 
6 Well Cell Culture Cluster Corning Incorporated 3516, NY 
3 mm  Fe2O3 ferrite magnets (700 gauss – 
0.07T) 
Magnet Expert, Tuxford, UK – F356F 
Piezo Actuator Physik Instrumente, Karlsruhe, Germany – 
PL088.30 
Signal generator Agilent 33210A 
High Voltage Piezo Driver Amplifier ENV 150, Piezosystemjena, Jena, Germany 
Laser Interferometer Vibrometer SIOS Meβtechnik GmBH Germany SP-S120 
 
Table 5.1: Table of materials and reagents used for Chapter V 
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5.2.2   Quantitative Real-Time (qRT-) PCR  
5.2.2.1   Trizol collagen gel extraction 
• In order to extract the collagen matrix from the samples trizol was utilised and this 
extraction was carried out inside the fume hood. 1 mL of trizol reagent was added to 
each sample. 
• The sample was then incubated at room temperature for 10 minutes to allow cell and 
matrix lysis. The samples were then centrifuged at 12000 g for 15 mins at 4°C. 
• The supernatant was then transferred to a fresh Eppendorf tube to which was added 
200 µL chloroform. 
• Following this the samples were shaken vigorously stirred for 20 seconds and left to 
incubate at room temperature for 3 mins. 
• The sample was then spun again at 12000 G for 15 mins at 4°C. 
The upper aqueous phase was then transferred to a clean Eppendorf tube, this volume 
was equivalent to 500-550 µL. This was done without disturbing the aqueous/organic 
interface. 
 
Note: Now that the analyte (RNA) was in the aqueous phase the remainder of the qRT-PCR 
experimentation was carried out as outlined in Chapter II, section 2.3.7.2 – 2.3.7.5. 
Gene Name Forward Primer Reverse Primer 
GAPDH TCAAGGCTGAGAACGGGAA TGGGTGGCAGTGATGGCA 
ONN AGAATGAGAAGCGCCTGGAG CTGCCAGTGTACAGGGAAGA 
OPN AGCTGGATGACCAGAGTGCT TGAAATTCATGGCTGTGGAA 
OCN CAGCGAGGTAGTGAAGAGACC TCTGGAGTTTATTTGGGAGCAG 
 
Table 5.2: Sequence of gene primers used to perform qRT-PCR. 
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5.2.3   Rheology  
Assessment of the physio-elastic properties of the collagen matrix was performed by carrying 
out dynamic frequency sweep experimentation. These frequency sweeps were performed by 
using a strain-controlled rheometer (Kinexus rotational rheometer system- Malvern). The 
parallel-plate used to perform the frequency sweep had a 20 mm diameter with a 0.25 mm 
gap. An integrated thermostat mechanism was used to maintain the sample temperature at 
25°C. In order to keep the sample hydrated and prevent drying out through evaporation the 
internal atmosphere was kept saturated through the use of a solvent trap.  An amplitude sweep 
was carried out and this confirmed no variation in elastic modulus (G′) and viscous modulus 
(G″). The amplitude sweep was performed up to a strain of 1% and these measurements were 
taken in a linear viscoelastic regime. The collagen matrix dynamic modulus was measured as 
a frequency function with a frequency range from 1 to 100 Hz. To ensure reproducibility all 
measurements per sample were performed in triplicates.  
5.2.4   Raman spectroscopy 
The 3D collagen gel matrix samples were nanokicked for 46 days, were partially dried and 
were directly assessed by Raman spectroscopy without further sample preparation. A 
Renishaw InVia Raman spectrometer with a 785 nm line focus laser was used to perform near 
IR spectroscopic scans. A reference standard of bovine cortical bone was used to assess the 
predominant finger print region spectrum for perfectly mineralised bone, and it was 
determined that 960 cm-1 and 1170 cm-1 were the predominant scattering wavenumbers. A 
light microscope (Leica) x 20 magnification was used to determine regions of interest and 
mineral deposition for assessment.  
5.2.5   In cell western assay 
The in cell western analysis was carried out as outlined in Section 3.2.4, Chapter 3. Note for 
the use of the collagen gels the primary antibody dilutions were increased to 1:20 for 
osteocalcin and osteopontin and 1:3500 for GAPDH. The secondary antibodies dilutions were 
prepared as 1:5000 for both osteocalcin and osteopontin and GAPDH. 
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5.2.6  Cell culture and collagen matrix preparation 
MSCs were sourced from Promocell and expanded cells were used for culturing in passages 
1-3. The basal media which was used to maintain the cells during experiments and for 
proliferation was DMEM (Sigma-Aldrich) supplemented with 10% FBS, 1% sodium pyruvate 
- Sigma (11 mg/ml), 1% MEM NEAA – Gibco (amino acids) and 2% antibiotics (6.74 U/mL 
penicillin-streptomycin, 0.2 µg/mL fungizone). MSCs were homogeneously seeded within a 
collagen matrix a population of approximately 1 × 105 per well. All culture was performed in 
an incubator at 37ºC with 5% CO2. The basal culture media was removed and replenished 2-3 
days. For the Osteogenic media positive control samples the DMEM basal media was also 
substituted with 100 µMol ascorbic acid and 50 nMol dexamethasone (Sigma). The collagen 
matrix was prepared by addition of 10x modified eagle’s media (First Link UK), FBS, basal 
media with the appropriate number of cells and 2.05 mg/mL rats tail Type I collagen in 0.16% 
acetic acid (First Link UK). The solution was homogeneously mixed by pipetting. Following 
this 0.1 M NaOH was added while on ice, till a permanent pink/red colour change (phenol red 
indicator) was observed, to form a gel. The samples were then quickly placed in a 37°C 
incubator avoiding agitation. 
 
5.2.7  Von Kossa assessment 
The Von Kossa staining technique using silver nitrate to coordinate with the phosphate 
component of the calcium hydroxyapatite complex was performed after 28 days of 
nanokicking. This technique was carried out as per Section 3.2.8.2 pg 65, however for this 
experiment the nuclear fast red counter stain was not performed with the 3D collagen gels. 
Image J software package was used to determine the staining intensity. 
 
 
5.2.8  Micro-computed tomography (micro-CT) analysis 
MSCs were nanokicked in 3D at 1000 Hz in a collagen gel extracellular matrix for 35 days 
the samples were fixed using 10% formaldehyde and transferred into PBS and subsequently 
imaged using micro-CT. The scans were then compared against unstimulated controls. Each 
well (of the 6 well plate) was seeded with ~ 750,000 cells. In order to image the samples all 
the gels for both the test sample (stimulated at 1000 Hz) and controls were combined together 
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in a separate cryo tube manufactured by Nunc A/S, with an internal diameter of 9.8 mm (± 0.1 
mm). Within the cryo tube polystyrene saturated with PBS was used to secure the gels in 
place. This ensured that the samples were unable to move during scanning. Polystyrene was 
utilised as it is radiolucent and allowed the gels to be imaged unobstructed. The micro-CT 
system which was used was a Skyscan 1172 (Orthopaedic engineering department University 
of Edinburgh S/N=08F01110). The data was reconstructed using Skyscan reconstruction 
software and scanning was performed with a 360° rotation (Resolution /pixel size = 2.9278 
µm, Source Voltage = 58 kV, Source Current = 171 µA, Exposure = 1178 ms). 
 
Note: The micro-CT work and the parameters chosen for analysis were carried out by Dr. 
Robert Wallace a member of the Orthopaedic engineering department at the University of 
Edinburgh. 
 
5.2.9  Statistics 
One way ANOVA was used to compare significance in PCR, in cell western and Von Kossa 
stain experiments. Two tailed, unpaired T-Tests were performed where a direct comparison 
was assessed between only two population groups. A sample population of between 3 and 6 
replicates were always used. All results are quoted as mean ± Standard deviation and the 
probability values have been quoted to an accuracy of 95%, 99% and 99.9% (*p < 0.05, **p < 
0.01 and *** p ≤ 0.001 respectively). 
 
5.3  Results 
5.3.1  Rheology determination  
Type I collagen was used as an osteoconducive extracellular matrix and MSCs were grown 
homogeneously spread within the 3D matrix. In order to confirm that a collagen gel matrix 
had been formed and not simply a viscous liquid, the elastic properties of the gel were 
determined. The incidence of a viscous liquid over a gel would negate the high frequency 
vibrational effect of the bioreactor and render osteogenesis unlikely. In order to assess the 
viscoelastic properties of the matrix rheology and modulus deformation was determined. For a 
gel the dynamic storage modulus is referred to as Gʹ and this term explains the amount of 
contortional strain required to deform or shear the elastic constituent of a gel. The loss 
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modulus is referred to as Gʹʹ and conversely this term explains the strain or force required to 
shear the viscous constituent of a gel. When Gʹ is equivalent to Gʹʹ this is the point at which 
liquefaction begins to occur. If Gʹ˃Gʹʹ the properties of a gel are present, and conversely if 
Gʹ˂Gʹʹ a liquid state is present.  
Collagen gels were assessed for rheology both with and without cells, with a seeding density 
of approximately 100,000. The gel was allowed to set in a 6 well plate and then removed and 
measured. In both cases it was found that a soft gel was present indicated by the greater 
measurement of Gʹ over Gʹʹ. In each case an elastic modulus of approximately 50 Pa was 
measured (Figure 5.1 A). 
 
Figure 5.1: Characterisation of the collagen gel: (A) Rheology assessment for collagen gel 
without MSCs, elastic modulus equalling ~ 50 Pa. (B) Rheology assessment for collagen gel 
with MSCs seeded with ~ 100,000 cells, elastic modulus equalling ~ 50 Pa.  
5.3.2  Transcript and protein assessment  
The osteogenic bioreactor with collagen gels seeded at a density of approximately 100,000 
MSCs was nanokicked (exposed to high frequency vertical displacements) at a frequency of 
1000 Hz for 21 days. Following this the MSCs were harvested and the RNA was extracted in 
order to perform qRT-PCR and gain a transcriptomic understanding. The mRNA of 3 main 
osteogenic genes i.e. OCN, OPN and ONN were assessed for the nanokicked samples. It was 
found that all three of these genes were up-regulated relative to unstimulated controls.  
Against a positive control - MSCs grown in osteogenic media without nanokicking (OSM); 
OPN and ONN were also up-regulated, with OPN being significant (Figure 5.2 A). However, 
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OCN was significantly over expressed for the positive control OSM samples. It also appeared 
that at 21 days time point the OPN and ONN were at lower expressed levels than the controls. 
This is simply due to the transcriptomic timeline for osteogenic expression by OSM. It is 
logical to deduce that if the assessment was performed a few days earlier these genes would 
certainly be upregulated. This unfortunately is one of the limitations of the technology.  
Further to this, a quantitative osteogenic protein assessment was also carried out for 
nanokicked samples in the 3D collagen matrix, using the in cell Western technique. The 
protein expressions of OCN and OPN at the 21 days’ time point was assessed relative to 
unstimulated controls and OSM positive controls.  As per the transcriptional assessment, at 
the protein level GAPDH too was once again used as an internal reference biological 
standard. The data showed that both OCN and OPN in the nanokicked samples were 
up-regulated and also gave the largest expression of these osteogenic proteins compared to 
both unstimulated and positive controls. An increase in OCN and OPN both at a transcript and 
a protein level was a general trend which was observed by nanokicking. A population of 3 
samples was used for both OCN and OPN (Figure 5.2 B). At a 2 weeks’ time point a direct 
assessment of nanokicked samples relative to unstimulated controls was carried out at the 
protein level for OCN, using a larger population of 6 samples. This was again determined 
using the technique of in cell western for quantification. The protein expression of OCN was 
observed to be over expressed and increased by approximately 40%. The data was strongly 
significant for the nanokicked samples relative to the unstimulated controls (Figure 5.2 C). 
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Figure 5.2: Transcriptomic assessment: (A) MSCs were exposed to nanokicking at 1000 Hz 
for the duration of 21 days in a collagen matrix. The transcriptomics were assessed against 
unstimulated controls and OSM positive controls (MSCs grown in osteogenic media) using 
the technique qRT-PCR. This showed an increase in OPN, OCN and ONN at this time point. 
N = 3 ±SD, * p < 0.05 by ANOVA, Protein assessment: (B) MSCs were exposed to 
nanokicking at 1000 Hz for 21 days in a collagen matrix, using in cell western the protein 
level expressions of OPN and OCN were assessed relative to unstimulated controls and 
positive controls OSM. Both OCN and OPN were observed to be increased relative to the 
controls, N = 3, results are mean ±SD. (C) MSCs exposed to nanokicking at 1000 Hz for 17 
days using in cell western, compared to unstimulated controls. A significant increase was 
observed, N = 6, results are mean ± SD ***p < 0.001 by unpaired, 2 tailed T-Test. 
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5.3.3  Calcium phosphate (Ca10(PO4)6)  bone mineralisation 
determination:   
Following on from affirmative osteogenic results at the transcriptomic and protein level, 
MSCs seeded in a collagen matrix were nanokicked for 28 days to determine the potential for 
bone mineralisation. The gel matrices including the cells were removed and then 
histologically stained for the presence of bound phosphate using the Von Kossa technique. 
The intensity of stain of the nanokicked samples were once again compared against the 
positive control, OSM samples and against unstimulated controls. Subsequently, the intensity 
of stain was quantified using the image J software package. The data showed that the 
phosphate deposition of the OSM and nanokicked samples was comparable and that the 
presence of phosphate was almost two fold relative to the unstimulated controls (Figure 5.3 A 
and B). Following on from this work, Raman spectroscopy was used to further assess, 
qualitatively and quantitatively, mineralisation in the gel matrix. MSCs were cultured for 46 
days while being exposed to the vibrational bioreactor i.e. being nanokicked at a frequency of 
1000 Hz. Relative to this, unstimulated controls were also cultured for the same duration of 
time. The test samples and control samples were then individually assessed in the Raman 
instrument using a laser attuned to the near IR to determine the presence of mineral deposits. 
The rationale for the long duration (46 days) of culture was two fold. Firstly, this was to 
assess the ability of the bioreactor to be cultured and maintain a sterile environment over a 
long period of time, and secondly to be certain that the MSCs had ample time to deposit 
mineralisation in the 3D collagen matrix, as the collagen matrix was a new condition being 
investigate.  
In the first instance a sample of bovine cortical bone was determined in the Raman fingerprint 
region from 500 to 1500 cm-1, which provides a specific profile for a particular compound. 
The resultant spectra showed that phosphate had a specific excitation scattering profile with a 
dominant peak at the 960 cm-1 wavenumber and subsequently a second peak at wavenumber 
1072 cm-1 (Figure 5.4 G). Given this data the Raman profile for the collagen gel matrix 
unstimulated control samples were assessed and this showed no noticeable Raman scattering 
at the wavelength/wavenumber of excitation used, and hence no peak interference between 
collagen and phosphate Raman spectra. (Figure 5.4 A&D). Following this, the samples which 
were nanokicked were also assessed. These samples gave a scattering pattern which was 
consistent with the profile observed for cortical compact bone confirming the presence of 
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Ca10(PO4)6 hydroxyapatite nodules, both the dominant peaks at wavenumber 960 cm
-1 and 
1072 cm-1 were observed (Figure 5.4 B&E and C&F). Quantification of these peaks showed 
that the value for the height and area for both peaks (960 cm-1 and 1072 cm-1) were much 
higher in the cortical bone control compared to the nanokicked samples. Comparative 
quantification for width at half height gave a value for the cortical bone which was 
approximately half that for each nanokicked sample assessed using Raman spectroscopy. This 
value provides an indication of the mineral properties or crystalline structure (Gentleman et 
al., 2009; Tarnowski et al., 2002), (Table 5.3). 
 
Figure 5.3: Bone mineralisation assessment: (A) Von Kossa staining was carried out after 28 
days of nanokicking at 1000 Hz in a collagen matrix. The intensity of stain was compared 
against unstimulated controls and osteogenic media cultured MSCs. An increased intensity of 
staining was observed for nanokicked samples against unstimulated samples. This was 
comparable to the osteogenic media samples (OSM). (B) Quantitative representation of 
intensity of Von Kossa stains, N = 5, results are mean ± SD ***p < 0.001 by one way 
ANOVA. 
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Figure 5.4: Bone mineralisation assessment: MSCs exposed to nanokicking at 1000 Hz for 46 
days in a collagen matrix and compared against unstimulated controls for Raman scattering in 
the fingerprint identification region. (A&D): profile for unstimulated control. (B&E) profile 
for nanokicked sample. (C&F) profile of duplicate nanokicked sample, N = 3, scale bar = 50 
µm. (G) Raman scattering for bovine cortical compact bone, this profile was used as a 
reference standard to characterise the Raman scattering pattern of bone.
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Bovine Cortical Bone 
(Perfectly 
Mineralised) 
1000 Hz  
T1 
1000 Hz  
T2 
1000 Hz  
T3 
Peak Raman 
Shift 960 cm
-1
 960 cm-1 960 cm-1 960 cm-1 
Height 134510 1041 3951 1787 
Area 3.030 x 10
7
 1.11 x 106 3.84 x 106 2.17 x 106 
FWHM 16.754 27.834 28.539 29.111 
 
Table 5.3: Quantitative results of Raman scattering. Raman spectra results for nanokicked 
samples relative to the reference standard of cortical compact bovine mineralised bone. 
Values are shown for the Raman shift peak height, area and full width at half height 
maximum (FWHM). 
 
Further to the results obtained when using Von Kossa and Raman spectroscopy to determine 
the formation of bone minerals, micro-CT was subsequently employed as a further 
confirmatory technique to assess the mineral deposits in the 3D collagen gel matrix. The 
samples were scanned (using X-rays) using a 360° rotation in horizontal transections through 
the collagen gel matrix. The light grey areas represent the collagen gel matrix with the black 
areas representing PBS or saturated polystyrene. The results showed that although on average 
only micro sized mineral deposits were observed there was a distinct difference in the 
presence or the amount of nodules observed between the test samples (i.e. nanokicked at 1000 
Hz) and the controls see (Figure 5.5). One of the largest nodules seen in the test sample had a 
diameter of approximately 500 µm with a depth of approximately 200 um (Figure 5.5A). This 
data shows that, in line with the Raman assessment and Von Kossa staining, the high 
frequency stimulation at 1000 Hz has an extra-osteogenic effect on the MSCs within a 3D 
matrix relative to the controls. 
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Figure 5.5: Calcium phosphate mineralisation assessment using micro-CT: MSCs cultured in 
a 3D collagen matrix were exposed to 1000 Hz nanokicking stimulation for 35 days. These 
samples were assessed against unstimulated controls. (A&B) micro-CT transectional scans 
through the collagen gel for the 1000 Hz test sample, small particulates of Ca10(PO4)6 
hydroxyapatite nodules observed. (C&D) micro-CT transectional scans through collagen gel 
of the control samples, scale bar = 200 µm, N=4 wells for the test samples and 3 wells for the 
controls. 
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5.4  Discussion 
The assessment of the collagen matrix confirmed that a soft gel had been formed capable of 
suspending the MSCs in a 3D orientation. A comparable elastic modulus for the gels seeded 
with and without cells (i.e. ~50 Pa) was observed. Various publications have shown that 
MSCs seeded in a matrix with a higher Youngs modulus (equivalent to pre-calcified bone ~ 
40 kPa) differentiate to osteoblasts (Engler et al., 2006; Engler et al., 2007). Although the 
stiffness of the gels used for the 3D matrix measured considerably lower than 40 kPa, it is 
likely that the modulus of the collagen matrix in situ tethered and strongly stretched within 
the 6 well plates is of a much higher stiffness than once removed. Hence MSCs seeded within 
gels in the bioreactor may be exposed to a much stiffer environment.  
It has been previously surmised that in a 2D format, force through vibrational acceleration and 
the weight of the media on top of the MSCs could, in part, be inductive of osteogenesis 
(Pacicca et al., 2002; Stonemetz et al., 2011). However, in 3D it is theorised that a 
compression effect induced by the high frequency vibrations or in effect a constant pressure 
wave is perhaps created through the gelatinous matrix. This could be creating shearing or 
even an applied force through pressure and compression which, it has been published, aids 
skeletal regeneration and the induction of osteogenesis (Henstock et al., 2013; Kim et al., 
2006; Neidlinger-Wilke et al., 2005). Unsurprisingly, we have also observed that an increased 
amount of collagen matrix (≥ 5 mL) also has a dissipating effect on the vibrational 
displacements which the MSCs are exposed to (Figure 4.4).  
The integrin attachments, focal adhesions and fibrillar adhesions which are formed in a 3D 
matrix differ from that formed in 2D. This is observed in the composition of α and β integrin 
subunits, protein complexes such as paxillin and the tyrosine phosphorylation of focal 
adhesion kinase (Bucci and Musitano, 2011). What’s more, the morphology and lay out of 
cells is also altered assuming a slender and more spindle shape akin to the in vivo state 
(Cukierman et al., 2001). It is a possibility that this morphology may also expose a greater 
surface area of the MSCs to the vibrational nanokicking effect due to an increased surface 
area relative to 2D cultured cells which are flattened and more oval (Cukierman et al., 2001; 
Hakkinen et al., 2011). It is hence speculated that this increased vibrational exposure may also 
increase osteogenesis in vivo. Interestingly, Lund et al have shown that inhibiting ERK 
(which is usually increased as a key component in the MAPK pathway to augment 
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osteogenesis (Kapur et al., 2003; Xu et al., 2014)) promotes collagen gel compaction and 
fibrillogenesis in 3D resulting in an amplification of the osteogenic phenotype (Lund et al., 
2009).  
Bearing in mind that the harmonics emitted by our bioreactor at 1000 Hz is audible to the 
human ear, and hence is strong enough to vibrate the stereocilia inside the cochlea, it is 
considered that these sonic vibrations may also have some beneficial effect on the MSCs at 
the nanoscale, which is not yet fully understood. Indeed Yun-Kyong Choi and colleagues 
have published that acoustic vibration (sub-sonic, ≤ 40 Hz at 1.0 V) has the potential to 
induce neurogenesis in adipose derived MSCs while inhibiting adipogenesis, stem cell 
maintenance and proliferation (Choi et al., 2012). It is then logical to assume that higher 
acoustic vibrations such as have been used here (1000 Hz) may have further capacities for 
MSCs differentiation including osteogenesis. 
The Raman quantification value of full width at half height maximum provides an indication 
of the crystalline structure or the density of mineralised bone Ca10(PO4)6 in the samples being 
analysed by giving an indication of mineral crystalline structure (Gentleman et al., 2009). 
Although it is not a direct correlation the data indicates that the structure and density of the 
mineral in the perfectly formed bovine cortical bone reference standard is more mineralised 
and hence is more dense or well formed, compared to the bone particulates grown by the 
vibrational bioreactor. This is also indicated by a more sharply formed peak with a greater 
intensity or level of Raman scattering. This is particularly observed, in the 960 cm-1 
wavenumber of the dominant peak provided by the stretching and bending motions created in 
the PO4 
3-
  V1 bonds as it interacts with electromagnetic radiation . Although the data confirms 
that the cortical bone reference standard is more compact and crystalline it does not appear to 
be on orders of magnitude greater (Gentleman et al., 2009; Tarnowski et al., 2002). 
The micro-CT results showed that in 3D, as is the case in 2D, the differentiated osteoblast 
cells will coalesce together to build or deposit ever increasing particulates of Ca10(PO4)6
 , 
(Pemberton et al., 2015) as smaller particulates on the sub 20 µm size were observed ranging 
all the way to approximately 500 µm. Nevertheless, although there was a distinctive difference 
between the test samples and the controls, in effect the amount of mineral deposited in the test 
samples was on the microscale. It is thought that a limiting factor was that insufficient raw 
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material was made available, i.e. if more calcium and phosphate would be provided to the 
cells they could subsequently grow even larger Ca10(PO4)6 particulates. 
5.5  Conclusion 
This unique research has shown that by using a novel bioreactor capable of providing 
sinusoidal high frequency (1000 Hz) displacements; it is possible to form mineral deposits in 
vitro in a 3D matrix. By histological staining it was clear that there was a significant increase 
in the deposition of mineral relative to unstimulated controls and further still the very specific 
technique of Raman spectroscopy also gave a definitive result that mineralisation did take 
place, and that the crystalline structure or density of the calcium phosphate minerals was not 
that much less than the cortical bone control. Further still by using the technique of micro-CT 
mineral deposits could be clearly observed in situ confirming the Raman and Von Kossa 
histological results.
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6.1    Introduction 
The ability to orchestrate the function and phenotype of somatic cells or even stem cells, in 
particular MSCs, is not only important but also a fundamental part of cell engineering. 
Understanding the physiological workings at a cellular level is the first step to tissue 
engineering and the potential replacement of functional organs or even the replacement of 
osseous tissue (Chistiakov, 2012; Conrad and Huss, 2005). For the control of proliferation, 
migration, differentiation and also, importantly, the artificial maintenance of potential (stem 
cells in an undifferentiated state), research has been performed using several techniques. 
When referring specifically to osteogenesis these include nanotopographical surfaces in 
particular disorder and order patterns (Dalby et al., 2007d; Dalby et al., 2006a), the 
application of a magnetic or electrical field (Ahuja et al., 2005)  and the manipulation of 
extracellular matrix stiffness and hydrostatic pressure (Engler et al., 2006; Liu et al., 2009a) 
and yet there are still other techniques (Prodanov et al., 2013). 
Here; through these past 5 chapters, it has been demonstrated that the use of high frequency 
stimulation of displacements on the nanoscale can be introduced to MSCs using an artificially 
made bioreactor to induce differentiation. What’s more it has been demonstrated that this 
bioreactor can be reproducibly and consistently made and that it can be used for both 2D and 
3D long-term sterile cell culture. Although as yet unproven, it is theorised that it may also be 
possible to bring about several other types of physiological differentiation in adult stem cells 
which have not come from the bone marrow or perhaps even iPSC or ESC (Choi et al., 2012; 
Pre et al., 2011a), by attuning the bioreactor to different frequencies and amplitudes. This 
research, however, has concentrated solely on osteogenesis achieved through the use of bone 
marrow (from the iliac crest) derived MSCs. 
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6.2  Vibrational Inducement of Osteogenesis 
A reasonable question is: how does nanokicking induced osteogeneis work? And although a 
definitive answer with all certainty cannot be given until even further work is carried out it is 
theorised that mechanotransduction must play a pivotal role.  
The integrins bridge to the extracellular matrix at specific attachment points (e.g. RGD) 
helping to relate mechanical information which occurs outside of the cell to the intracellular 
compartments, in particular to the nucleus where transcription factors can be 
up/down-regulated to bring about a distinctive phenotype, See (Figure 1.5), from the 
introduction. The data throughout this thesis suggests that this maybe a key means by which 
nanokicking mechanotransductively induces osteogenesis and differentiation in MSCs (Dalby 
et al., 2014a; Wang et al., 2009b). It has been observed that RUNX2 and OCN as well as 
other mRNA (gene transcripts) specific for osteoblast formation are related to the 
up-regulation of ERK1&2 and FAK which are closely linked to the MAPK pathway. This 
pathway is known to bring about a downstream increase in RUNX2 which commences in the 
focal adhesions which are physically linked to the intergins (Tsimbouri et al., 2012a). This 
research has also consistently shown a general trend of the increase of OCN and OPN (both 
genetic and protein) through nanokicking induced osteogenesis. 
A physiological property of bone which may also add to osteogenesis is its piezoelectric 
attribute. We know that the inorganic component of bone is calcium phosphate hydroxyapatite 
Ca10(PO4)6(OH)2, while the organic content of bone is primarily made up of collagen. It has 
been previously published that collagen is piezo electric; however this property of collagen is 
only witnessed when it is dry. For this to occur when collagen is wet or hydrated it requires 
mechanical stimulation at much higher frequencies i.e. kHz or perhaps even the MHz range 
(Reinish and Nowick, 1975). Interestingly, the mechanical stimulation using the piezo 
actuator which has been carried out in this thesis was performed in the kHZ range. The unique 
effect of this is that an electric current also appears to have the ability to augment the growth 
or regeneration of osseous tissue (Goldstein et al., 2010) . An electrical charge also has the 
ability to induce or dictate polarization, and as a result, influence the directional movement of 
cells, a process referred to as galvanotaxis (Cohen et al., 2014). This could mean that an 
electric charge could also influence the direction or positioning of bone growth. A further 
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hypothesis is that the piezoelectric property of bone may also be used to orchestrate osteoblast 
movement and physiological activity (Finkelstein et al., 2007).  
Just like the mechanical properties of the piezo actuator, the deformation of bone through 
weight bearing may also stimulate its piezo effect causing an electric dipole to form which 
would be observed by the osteoblasts on the surface of the bone and hence by the osteocytes 
which are connected to osteoblasts through canals called canaliculi see (Figure 1.2). Further 
still, the osteoclasts are also connected to the osteocytes through these canals. These 
connections and canals resemble the copper wire tubing and connections in an electrical 
circuit, or even the neuronal connections within brain and spinal tissue, which too 
incidentally, possess electrical activity (Salanki and Varanka, 1969). In effect there may 
possibly be an information (perhaps electrical, vibrational) network between the osteoblasts, 
osteocytes and osteoclasts which serves the purpose of modelling and remodelling at defined 
sites in growing bone or causing osteoblastic differentiation. Having explained these 
piezoelectric properties of collagen and bone and what might be an information network 
between the cells that make up bone; it is possible to deduce that our high frequency 
bioreactor may be stimulating these electrical and mechanical mechanisms through 
nanokicking: which could subsequently bring about osteogensis. Interestingly it has been 
suggested that through polarization a negative charge would result at regions of osteoclast 
proliferation and regions with a positive charge would cause osteoblast clustering (Fernandez 
et al., 2012). It is worth noting however, that different voltages/ currents may have altering 
affects and at the micro/nano scale the assumption would be that very low levels (≤ micro 
volts) would potentially be observed through nanokicking. 
At the high frequencies of 1000 Hz – 5000 Hz which have been investigated, audible sonic 
vibrations can be detected by the human ear; hence these vibrations have a nanoscale acoustic 
effect also. It may be that this nanoacoustic effect may also provide an additive advantage for 
stem cell differentiation. It has been published that even lower sonic vibrations can affect 
stem cell lineage commitment, in particular neurogenesis from MSCs (Choi et al., 2012) . 
What’s more, low intensity pulsed ultrasonography may also provide a beneficial effect on the 
regeneration of bone fractures (Claes and Willie, 2007). 
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In understanding osteogenic differentiation, we have observed in 3D that it is of importance to 
also consider the biomimetic attribute of any design or osteogenic scaffold, and hence efforts 
have been made to culture the MSCs as close as possible to the in vivo osseous natural state. 
Collagen, which is the dominant protein that makes up the organic component of bone, has 
been utilised as the extracellular matrix used in the 3D bioreactor model, and in line with 
biomimetics, collagen may to have an additive affect on the osteogenic phenotype when 
coupled with nanokicking (Ren et al., 2015; Sumanasinghe et al., 2006). In the osteogenic 
experiments performed in 2D, there was no collagen scaffold used, however MSCs do have 
the potential to form fibroblasts (they were first described by Friedenstein as colony forming 
unit fibroblasts) (Friedenstein, 1976; Friedenstein et al., 1968) which form the extracellular 
matrix including collagen. Hence the piezo electric properties of collagen described in the 
paragraphs above may have also been of importance even in the experiments performed with 
nanokicking in 2D.  
Further to explain the design used in the 2D bioreactor and the osteogenic effect observed; it 
has been previously published that an increased weight or hypergravity (the weight of the 
media above the cells would be amplified by the force of nanokicking), and  it has also been 
published that an increased weight would also be osteogenic (Kacena et al., 2004; Prodanov et 
al., 2013). It is hypothesised that this hypergravity effect may also be translated in the 3D 
culture system. The rheological assessments see (Figure 5.1), has shown that, in effect, a very 
soft gel is surrounded by aqueous media. This design may provide a compression wave effect 
through the gel caused by the high frequency nanokicks. This compression could be 
interpreted as weight bearing by the cultured MSCs even in 3D, resulting in further 
osteogensis. Credence to this fact is also seen in that astronauts in a low gravity i.e. a low 
weight compressive effect on their bones suffer from musculoskeletal atrophy (Miyamoto et 
al., 1998) . Further, this hypothesis is in agreement with Wolff’s Law, in that healthy osseous 
tissue will accommodate added strain or weight (activation and up-regulation of osteoblasts) 
by becoming fortified (Polk, 2011) .  
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6.3     Conception of the Novel 3D bioreactor: From 2D – 3D 
The 2D piezo actuator bioreactor was found to be suitable for use when interrogated for 
thermal and mechanical stability. The design which was used was also importantly not 
susceptible to shear force (Nikukar et al., 2013). In terms of thermal consistency, the piezo 
actuators were made of ceramics which was an excellent insulator (Figure 2.4). The use of 
heated polycaprolactone as a biocompatible glue was also suitable to securely fasten the 
polycarbonate NSq-50 nanotopographical substrates to the Petri dish efficiently transferring 
the piezo nanodisplacement, as was confirmed by the interferometric measurements (Figure 
2.6). 
 
The interferometric empirical measurements also corroborated with the ANSYS finite 
element data and fortunately GAPDH was found to be a robust and suitable internal biological 
reference standard which could be used to assess osteogenic change both at a transcript 
expression and protein expression level. These data altogether provided confidence that the 
2D bioreactor was capable of transferring a sustained mechanical vertical displacement at 
high frequency through a Petri dish to MSCs cultured on the surface, with the proven 
induction of osteogenesis (Pemberton et al., 2015). 
 
Nevertheless, the use of the 2D bioreactor (Figure 2.2) which was inherited at the beginning 
of this PhD meant that the reproducibility between samples and in particular between 
individual piezo actuators could potentially be a source of error. What’s more, the use of the 
2D bioreactor with loose electrical wires meant that the bioreactor was cumbersome. Safety 
issues from loose wires, a time consuming set up for experiments, (in part due to using 
different glues for construction before every experiment), and the destruction of the individual 
piezo actuators over time through constant removal and attachment were some of the 
necessity drivers for change. A further problem was the need to change the media every 2 or 3 
days within the incubator during long-term experiments i.e. a point at which sterility could be 
compromised. As a result of these shortcomings, the 3D bioreactor was conceived and 
designed to correct these failings with a plan which was conducive to eventual 3D GMP 
culture and ease of use with reproducible effect between all piezo actuators (Figure 6.2). It 
was designed as a technologically novel genre of bioreactor (a nanovibrational bioreactor) as 
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opposed to the perfusion, spinner flasks, EMF etc. bioreactors which had previously been 
developed. This bioreactor does not require flow through but instead nutrient rich media 
would be added and removed from the top surface as and when required, depending on the 
vibrational mechanical forces for the movement of nutrients through diffusion. In part 
concepts learned from LEAN and 6 Sigma were employed in this design. These principles 
teach understandings in efficiency and productivity, and that if something is cumbersome or 
not value adding it should be dispensed with or optimised. They ask of one to keep in mind 
what is best for, or the need of the stakeholder and then this is incorporated into a thought 
process and then the design (Haenke and Stichler, 2015; Mason et al., 2015). 
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Figure 6.1: The novel 3D bioreactor (A) Shows a longitudinal section of the bioreactor which 
was designed and optimised from the bioreactor shown in figure 2.2 A. (B) Aerial view of the 
3D bioreactor showing cultured MSCs within a collagen matrix in a 6 well plate. 
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Although there are several osteogenic bioreactors on the market already ranging from 
perfusion, centrifugal and rotating bioreactors, see (Table 1.1), the uniqueness of the 
nanokicking bioreactor comes from the method in which it brings about osteoblast 
differentiation, it’s cheaper running costs  and perhaps most fundamental, the fact that it can 
bring about osteogenesis without the requirement of osteogenic media, growth factors, 
chemical compounds or intricate 3D scaffolds (e.g. dexamethasone, rhBMP2),  (Ha et al., 
2013; Rauh et al., 2011a; Yeatts et al., 2013). Hence for the most part the present commercial 
bioreactors require an osteogenic additive which also increases running cost and complexity. 
It is envisaged that long-term this bioreactor may possibly lend itself to clinical use and GMP 
manufacture of artificially produced autologous ossesous tissue for regenerative medicine or 
simply to produce autologous ossesous tissue for testing patient specific efficiency of a novel 
treatment in the burgeoning field of personalised medicine. This ambition however will 
require phase I – III clinical trials and collaboration with the pharmaceutical industry. 
6.4   Conclusion 
In conclusion, the hypothesis and aim of this thesis investigated over the past 3½ years has for 
the most part been met, nevertheless more research could still be performed. The design 
engineered for the 2D bioreactor facilitated high frequency vibrational stimulation of MSCs. 
This was found to be fit for purpose when interrogated for thermal, mechanical and biological 
integrity. This bioreactor was hence suitable to induce osteogenesis of MSCs in 2D and to 
enhance osteogenesis even further when coupled with an osteogenic (NSq-50) 
nanotopography. The 3D bioreactor; while having bioequivalence with the previous design is 
more simple and elegant to use and may have real world practical applications academically 
in research laboratories and clinically to be able to treat musculoskeletal conditions such as 
bone fractures, and potentially artificially grow replacement bone tissue for patients who have 
had osteosarcoma excisions. 
 
6.5  Future Directions 
The assessment of other sources of stem cells, such as hematopoietic, iPSC, ES may perhaps 
yield interesting results.  A catalogued design of experiments should be performed, varying 
frequencies for each cell type, from 1 Hz – 5000 Hz and in the first instance assessing the 
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genetic landscape by microarray (or microRNA and mRNA determination). This could first 
be performed in 2D and then again in various 3D matrices. It is suggested that frequencies 
such as 396 Hz, 444 Hz, 639 Hz, 741 Hz and 852 Hz may be attuned to the resonance 
frequencies of the different tissues which make up the body and may have regenerative 
potential. It may be of interest to assess 528 Hz. It is theorised that this frequency may also 
have regenerative properties including DNA repair, delaying cell senescence. 
Further research at the Schumann resonance frequency at 7.8 Hz may also provide interesting 
results for neurogenesis, as it is thought that the electrical impulses in the brain may resonate 
near that frequency also. Interestingly Nikola Tesla was also researching free wireless energy 
at an approximate frequency (7.8 Hz) in the Colorado Springs during the early 20th Century.  
As far as osteogenic use of the bioreactor it would also be important to assess the potential of 
AD-MSC as these may be a more efficacious cell type than the BM-MSC. What’s more they 
would be an easily retrievable source of MSCs, alleviating the patient distress caused by the 
removal of bone marrow aspirates. Research suggests that MSCs sourced from the adipose 
tissue may be more robust or viable (Dmitrieva et al., 2012a). It is also theorised that in 3D 
(and perhaps also in 2D) culture there may be other frequencies that have been overlooked 
which may be more osteogenic than 1000 Hz. It will hence be worthwhile to reinvestigate 
frequencies from 500 Hz – 5000 Hz. Furthermore, the adition of raw material for the 
osteoblasts (calcium and phosphate) particulates in the collagen matrix should expedite 
mineral deposition as well as increase the rigidity of the matrix making it more osteoinductive 
and vibrationally transductive. 
Although the initial investigation of the bioreactor and piezo technology was to consider its 
affect on stem cells, it is believed that this technology may also lend itself favourably to 
several other biotechnological areas of research. Other future directions may include the 
determination of the affect of various frequencies and amplitude on several kinds of malignant 
cell types to observe if this may limit the rate of division of cancer cells. This may be 
achieved by aligning the frequency used with different biological resonant frequencies of 
cancer cell types. It is envisaged that this same modus operandi may be favourably used to 
assess the effect of vibrational and acoustic stimulation on pathogenic cell types; such as 
bacteria, viruses and protozoa.
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